<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38064489</article-id><article-id pub-id-type="pmc">PMC10732364</article-id>
<article-id pub-id-type="doi">10.1371/journal.pntd.0011274</article-id><article-id pub-id-type="publisher-id">PNTD-D-23-00401</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Parasitology</subject><subj-group><subject>Parasite Groups</subject><subj-group><subject>Apicomplexa</subject><subj-group><subject>Plasmodium</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject><subj-group><subject>Nested Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject><subj-group><subject>Nested Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>RNA</subject><subj-group><subject>Non-coding RNA</subject><subj-group><subject>Ribosomal RNA</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Ribosomes</subject><subj-group><subject>Ribosomal RNA</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular structures and organelles</subject><subj-group><subject>Ribosomes</subject><subj-group><subject>Ribosomal RNA</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Parasitic Diseases</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Species Interactions</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Zoology</subject><subj-group><subject>Entomology</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Arthropoda</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Zoology</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Arthropoda</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Protozoans</subject><subj-group><subject>Parasitic Protozoans</subject><subj-group><subject>Malarial Parasites</subject><subj-group><subject>Plasmodium Ovale</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Real-time PCR detection of mixed <italic toggle="yes">Plasmodium ovale curtisi</italic> and <italic toggle="yes">wallikeri</italic> infections in human and mosquito hosts</article-title><alt-title alt-title-type="running-head">Detection of mixed <italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi</italic> and <italic toggle="yes">wallikeri</italic> malaria</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0001-0069-1353</contrib-id><name><surname>Potlapalli</surname><given-names>Varun R.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Muller</surname><given-names>Meredith S.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ngasala</surname><given-names>Billy</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ali</surname><given-names>Innocent Mbulli</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Na</surname><given-names>Yu Bin</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Williams</surname><given-names>Danielle R.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kharabora</surname><given-names>Oksana</given-names></name><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chhetri</surname><given-names>Srijana</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Mei S.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Carey-Ewend</surname><given-names>Kelly</given-names></name><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Feng-Chang</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="aff005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mathias</surname><given-names>Derrick</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="aff006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tarimo</surname><given-names>Brian B.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="aff007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Juliano</surname><given-names>Jonathan J.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Parr</surname><given-names>Jonathan B.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4516-723X</contrib-id><name><surname>Lin</surname><given-names>Jessica T.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Institute of Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, Cameroon</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, United States of America</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Florida Medical Entomology Laboratory, Institute of Food &#x00026; Agricultural Sciences, University of Florida, Vero Beach, Florida United States of America</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Vector Immunity and Transmission Biology Unit, Department of Environmental Health and Ecological Sciences, Ifakara Health Institute-Bagamoyo Office, Bagamoyo, Tanzania</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Jaffe</surname><given-names>Charles L.</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Hebrew University-Hadassah Medical School, ISRAEL</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>jessica_lin@med.unc.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>8</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2023</year></pub-date><volume>17</volume><issue>12</issue><elocation-id>e0011274</elocation-id><history><date date-type="received"><day>4</day><month>4</month><year>2023</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 Potlapalli et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Potlapalli et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pntd.0011274.pdf"/><abstract><p><italic toggle="yes">Plasmodium ovale curtisi</italic> (<italic toggle="yes">Poc)</italic> and <italic toggle="yes">Plasmodium ovale wallikeri</italic> (<italic toggle="yes">Pow</italic>) represent distinct non-recombining <italic toggle="yes">Plasmodium</italic> species that are increasing in prevalence in sub-Saharan Africa. Though they circulate sympatrically, co-infection within human and mosquito hosts has rarely been described. Separate 18S rRNA real-time PCR assays that detect <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> were modified to allow species determination in parallel under identical cycling conditions. The lower limit of detection was 0.6 plasmid copies/&#x003bc;L (95% CI 0.4&#x02013;1.6) for <italic toggle="yes">Poc</italic> and 4.5 plasmid copies/<italic toggle="yes">&#x003bc;</italic>L (95% CI 2.7&#x02013;18) for <italic toggle="yes">Pow</italic>, or 0.1 and 0.8 parasites/&#x003bc;L, respectively, assuming 6 copies of 18s rRNA per genome. However, the assays showed cross-reactivity at concentrations greater than 10<sup>3</sup> plasmid copies/&#x003bc;L (roughly 200 parasites/<italic toggle="yes">&#x003bc;</italic>L). Mock mixtures were used to establish criteria for classifying mixed <italic toggle="yes">Poc/Pow</italic> infections that prevented false-positive detection while maintaining sensitive detection of the minority ovale species down to 10<sup>0</sup> copies/&#x003bc;L (&#x0003c;1 parasite/&#x003bc;L). When the modified real-time PCR assays were applied to field-collected blood samples from Tanzania and Cameroon, species identification by real-time PCR was concordant with nested PCR in 19 samples, but additionally detected two mixed <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> infections where nested PCR detected a single <italic toggle="yes">Po</italic> species. When real-time PCR was applied to oocyst-positive <italic toggle="yes">Anopheles</italic> midguts saved from mosquitoes fed on <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic>-infected persons, mixed <italic toggle="yes">Poc/Pow</italic> infections were detected in 11/14 (79%). Based on these results, 8/9 <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> carriers transmitted both <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species to mosquitoes, though both <italic toggle="yes">Po</italic> species could only be detected in the blood of two carriers. The described real-time PCR approach can be used to identify the natural occurrence of mixed <italic toggle="yes">Poc/Pow</italic> infections in human and mosquito hosts and reveals that such co-infections and co-transmission are likely more common than appreciated.</p></abstract><abstract abstract-type="summary"><title>Author summary</title><p><italic toggle="yes">Plasmodium ovale</italic>, one of five species of malaria known to infect humans, in fact represents two distinct species, <italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi</italic> (<italic toggle="yes">Poc</italic>) and <italic toggle="yes">wallikeri</italic> (<italic toggle="yes">Pow</italic>), that can only be distinguished using molecular diagnostics. Though <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> circulate in the same regions in Africa and Asia, mixed infections, where both are found in the same human host, have rarely been described. In this study, we modified existing real-time PCR assays targeting 18S rRNA and developed an algorithm to detect mixed <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> infections. We then applied these assays to field-collected samples from Tanzania and Cameroon, including blood samples from <italic toggle="yes">P</italic>. <italic toggle="yes">ovale-</italic>infected persons and <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic>-positive mosquito midguts saved from mosquito feeding assays. We detected both <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> in roughly 10% of human <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> blood-stage infections, and surprisingly, in a majority of blood-fed mosquitoes. This suggests that <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> co-infect the same hosts more frequently than previously realized.</p></abstract><funding-group><award-group id="award001"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap>
</funding-source><award-id>R01AI137395</award-id><principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4516-723X</contrib-id>
<name><surname>Lin</surname><given-names>Jessica T.</given-names></name>
</principal-award-recipient></award-group><award-group id="award002"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap>
</funding-source><award-id>R21AI148579</award-id><principal-award-recipient>
<name><surname>Parr</surname><given-names>Jonathan B.</given-names></name>
</principal-award-recipient></award-group><award-group id="award003"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap>
</funding-source><award-id>R21AI152260</award-id><principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4516-723X</contrib-id>
<name><surname>Lin</surname><given-names>Jessica T.</given-names></name>
</principal-award-recipient></award-group><award-group id="award004"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap>
</funding-source><award-id>K24AI134990</award-id><principal-award-recipient>
<name><surname>Juliano</surname><given-names>Jonathan J.</given-names></name>
</principal-award-recipient></award-group><award-group id="award005"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap>
</funding-source><award-id>107741/A/15/Z</award-id><principal-award-recipient>
<name><surname>Ali</surname><given-names>Innocent Mbulli</given-names></name>
</principal-award-recipient></award-group><award-group id="award006"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100020171</institution-id><institution>Foreign, Commonwealth and Development Office</institution></institution-wrap>
</funding-source><award-id>x</award-id><principal-award-recipient>
<name><surname>Ali</surname><given-names>Innocent Mbulli</given-names></name>
</principal-award-recipient></award-group><award-group id="award007"><funding-source>
<institution>DELTAS Africa</institution>
</funding-source><award-id>x</award-id><principal-award-recipient>
<name><surname>Ali</surname><given-names>Innocent Mbulli</given-names></name>
</principal-award-recipient></award-group><funding-statement>This work was supported by the National Institutes of Health through grants R01AI137395 to JTL, R21AI148579 to JP and JTL, R21AI152260 to JTL, and K24AI134990 to JJJ. IMA was supported by a postdoctoral fellowship from the Wellcome Trust [grant # 107741/A/15/Z] and the UK Foreign, Commonwealth and Development Office, with support from the Developing Excellence in Leadership, Training and Science in Africa (DELTAS Africa) program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="4"/><page-count count="15"/></counts><custom-meta-group><custom-meta><meta-name>PLOS Publication Stage</meta-name><meta-value>vor-update-to-uncorrected-proof</meta-value></custom-meta><custom-meta><meta-name>Publication Update</meta-name><meta-value>2023-12-20</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p><italic toggle="yes">Plasmodium ovale curtisi</italic> (<italic toggle="yes">Poc</italic>) and <italic toggle="yes">Plasmodium ovale wallikeri</italic> (<italic toggle="yes">Pow</italic>), long recognized simply as <italic toggle="yes">Plasmodium ovale</italic> due to their similar morphology under the microscope, in fact represent two distinct, non-recombining malaria species [<xref rid="pntd.0011274.ref001" ref-type="bibr">1</xref>,<xref rid="pntd.0011274.ref002" ref-type="bibr">2</xref>]. <italic toggle="yes">Plasmodium ovale</italic> (<italic toggle="yes">Po</italic>, inclusive of both species) has more commonly been reported from West Africa [<xref rid="pntd.0011274.ref003" ref-type="bibr">3</xref>], but its prevalence based on recent PCR surveys appears to be increasing in East Africa [<xref rid="pntd.0011274.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pntd.0011274.ref008" ref-type="bibr">8</xref>]. There is some evidence that the two species differ in their latency period or relapse periodicity, as well as their presentation in travelers [<xref rid="pntd.0011274.ref003" ref-type="bibr">3</xref>,<xref rid="pntd.0011274.ref009" ref-type="bibr">9</xref>&#x02013;<xref rid="pntd.0011274.ref012" ref-type="bibr">12</xref>]. Still, the extent to which <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> differ in their biology, epidemiology, and clinical manifestations in Africa, where they are most frequently found, remains an active area of research [<xref rid="pntd.0011274.ref013" ref-type="bibr">13</xref>,<xref rid="pntd.0011274.ref014" ref-type="bibr">14</xref>].</p><p>Interestingly, though both <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species circulate sympatrically in time and space, mixed infections of the two species have rarely been described, with &#x0003c;20 cases of <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> co-infection reported across &#x0003e;35 studies encompassing 1,515 <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> cases in the literature [<xref rid="pntd.0011274.ref003" ref-type="bibr">3</xref>,<xref rid="pntd.0011274.ref013" ref-type="bibr">13</xref>,<xref rid="pntd.0011274.ref015" ref-type="bibr">15</xref>,<xref rid="pntd.0011274.ref016" ref-type="bibr">16</xref>]. Since the existence of mixed <italic toggle="yes">Plasmodium</italic> infections of other species is well-documented, we suspected this was due to technical limitations rather than biological constraints. We adapted previously published nested and real-time PCR (qPCR) assays for <italic toggle="yes">Po</italic> species detection to establish criteria for defining when both <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> are present, and then applied these assays to <italic toggle="yes">Po</italic>-positive isolates from Africa. Our methods and findings add to the growing body of work on better defining the epidemiology of these two species in Africa.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Methods</title><sec id="sec003"><title>Ethics statement</title><p>This study was approved by institutional review boards at the University of North Carolina (IRB #16&#x02013;0079), Tanzania National Institute for Medical Research (TransMIT 3639/Vol 34/005), Muhimbili University of Health and Allied Sciences (MUHAS-REC-5-2021-124), Ifakara Health Institute (IHI/IRB/AMM/ No:12&#x02013;2020), and the Cameroon Baptist Convention Health Board (IRB2019-40). Written informed consent was obtained from all participants.</p><p>Previously published molecular assays for the detection and differentiation of <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species were reviewed (<bold><xref rid="pntd.0011274.t001" ref-type="table">Table 1</xref></bold>). Based on initial testing, a nested PCR (nPCR) assay from Calderaro, et. al [<xref rid="pntd.0011274.ref017" ref-type="bibr">17</xref>,<xref rid="pntd.0011274.ref018" ref-type="bibr">18</xref>] and real-time qPCR assays from Perandin, et al. [<xref rid="pntd.0011274.ref019" ref-type="bibr">19</xref>] and Calderaro, et. al [<xref rid="pntd.0011274.ref020" ref-type="bibr">20</xref>,<xref rid="pntd.0011274.ref021" ref-type="bibr">21</xref>], all targeting the small subunit RNA gene (18S rRNA), were selected for further assay development and comparison.</p><table-wrap position="float" id="pntd.0011274.t001"><object-id pub-id-type="doi">10.1371/journal.pntd.0011274.t001</object-id><label>Table 1</label><caption><title>Published molecular assays to distinguish <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species, <italic toggle="yes">Po curtisi</italic> (<italic toggle="yes">Poc</italic>) and <italic toggle="yes">Po wallikeri</italic> (<italic toggle="yes">Pow</italic>), and their application to clinical samples.</title></caption><alternatives><graphic xlink:href="pntd.0011274.t001" id="pntd.0011274.t001g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><th align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Target</th><th align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Method details (Primers/probes)</th><th align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Country</th><th align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic></th><th align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</th><th align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</th><th align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"><italic toggle="yes">Poc/Pow</italic> mixed</th><th align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Comments</th></tr></thead><tbody><tr><td align="center" colspan="9" rowspan="1">
<bold>Nested PCR</bold>
</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><bold>Calderaro, et. al.</bold> [<xref rid="pntd.0011274.ref017" ref-type="bibr">17</xref>]<break/>J Clin Micro, 2007</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><bold>18S rRNA</bold><break/>(~800bp)</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">rPLU1, rPLU5 (<italic toggle="yes">Plasmodium</italic>)<break/>rOVA1, rOVA2 (<italic toggle="yes">Poc</italic>)<break/>rOVA1v, rOVA2v (<italic toggle="yes">Pow</italic>)</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Return travelers to Italy (n = 62)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">10</td><td align="center" colspan="3" style="background-color:#F2F2F2" rowspan="1">Not specified</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Oguike, et al.</bold> [<xref rid="pntd.0011274.ref022" ref-type="bibr">22</xref>]<break/>Int J Parasitol, 2011</td><td align="left" rowspan="1" colspan="1"><bold><italic toggle="yes">PoTRA</italic></bold><break/>(tryptophan-rich antigen)</td><td align="left" rowspan="1" colspan="1">PoTRA3 fwd, PoTRA3 rev (44 cycles)<break/>PoTRA5 fwd, PoTRA5 rev (44 cycles)<break/>245 bp product (<italic toggle="yes">Pow</italic>)<break/>317&#x02013;335 bp product (<italic toggle="yes">Poc</italic>)</td><td align="left" rowspan="1" colspan="1">Congo (n = 6)<break/>Equatorial Guinea (n = 49)<break/>Uganda (n = 1,254)</td><td align="center" rowspan="1" colspan="1">6<break/>4<break/>36</td><td align="center" rowspan="1" colspan="1">2<break/>2<break/>16</td><td align="center" rowspan="1" colspan="1">4<break/>2<break/>20</td><td align="center" rowspan="1" colspan="1">0<break/>0<break/>1*</td><td align="left" rowspan="1" colspan="1">*1 mixed Poc/Pow not detected by PoTRA assay, but confirmed with <italic toggle="yes">pog3p</italic> sequence analysis.</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><bold>Tanomsing, et al.</bold> [<xref rid="pntd.0011274.ref023" ref-type="bibr">23</xref>]<break/>J Clin Micro, 2013</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">PoTRA</italic>
</bold>
</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">PoTRA-F, PoTRA3 rev (25 cycles)<break/>PoTRA-F + PocTRA-R (30 cycles)<break/>299 bp or 317 bp product (<italic toggle="yes">Poc</italic>)<break/>PoTRA-F + PowTRA-R (30 cycles)<break/>245 bp product (<italic toggle="yes">Pow</italic>)</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Not specified (n = 17)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">17</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">7<break/></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">10</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">0</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Detection sensitivity: 2 to 10 parasites/&#x003bc;L blood.</td></tr><tr><td align="center" colspan="9" rowspan="1">
<bold>Real-time qPCR</bold>
</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><bold>Perandin, et al.</bold> [<xref rid="pntd.0011274.ref019" ref-type="bibr">19</xref>]<break/>J Clin Micro 2004</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>18S rRNA</bold>
</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">OVA-F, OVA-R<break/>Ova (VIC) probe<break/>(45 cycles, 60&#x000b0;C annealing)</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Returning travelers to Italy<break/>(n = 61)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">3</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">3*</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">0</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">0</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Detects <italic toggle="yes">Po curtisi</italic><break/>*Ranging 360&#x02013;25000 parasites/uL<break/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Oguike, et al.</bold> [<xref rid="pntd.0011274.ref022" ref-type="bibr">22</xref>]<break/>Int J Parasitol, 2011</td><td align="left" rowspan="1" colspan="1"><bold><italic toggle="yes">Porbp2</italic></bold><break/>(Reticulocyte-binding protein homologue)</td><td align="left" rowspan="1" colspan="1">Porbp2TMfwd, Porbp2TMrev<break/>Sybr Green (40 cycles)<break/>73&#x000b0;C melt peak (<italic toggle="yes">Poc</italic>)<break/>74&#x000b0;C melt peak (<italic toggle="yes">Pow</italic>)</td><td align="left" rowspan="1" colspan="1">Equatorial Guinea (n = 49)<break/>Uganda (n = 1254)</td><td align="center" rowspan="1" colspan="1">4<break/>36</td><td align="center" rowspan="1" colspan="1">2<break/>16</td><td align="center" rowspan="1" colspan="1">2<break/>20</td><td align="center" rowspan="1" colspan="1">0<break/>0</td><td align="left" rowspan="1" colspan="1">Melting curve analysis assay</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><bold>Calderaro, et al.</bold> [<xref rid="pntd.0011274.ref020" ref-type="bibr">20</xref>]<break/>PLoS One 2012</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>18S rRNA</bold>
</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">OVA-Fv primer, OVA-Rv primer<break/>Ovav (FAM) probe<break/>(55 cycles, 60&#x000b0;C annealing)</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Not specified (n = 31)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">31</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">20</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">11</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">0</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Detects <italic toggle="yes">Po wallikeri</italic><break/>Ct 54 threshold for positivity<break/>Parasitemia range: 50 to 20,500 parasites/uL<break/>Detection sensitivity of 50 plasmid copies/uL</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Nijhuis, et al.</bold> [<xref rid="pntd.0011274.ref024" ref-type="bibr">24</xref>]<break/>Eur J Clin Microbiol Infect Dis, 2018</td><td align="left" rowspan="1" colspan="1">
<bold>18S rRNA</bold>
</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi-s</italic> forward<break/><italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi-TXR-MGB</italic> probe<break/><italic toggle="yes">P</italic>. <italic toggle="yes">ovale wallikeri-s</italic> forward<break/><italic toggle="yes">P</italic>. <italic toggle="yes">ovale wallikeri-TXR-MGB</italic> probe<break/><italic toggle="yes">P</italic>. <italic toggle="yes">generic-as</italic> reverse<break/>(45 cycles)</td><td align="left" rowspan="1" colspan="1">Not specified (n = 56)</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" colspan="3" rowspan="1">Not specified<break/></td><td align="left" rowspan="1" colspan="1">Multiplex real-time qPCR assay</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><bold>Lamien-Meda, et al.</bold> [<xref rid="pntd.0011274.ref025" ref-type="bibr">25</xref>]<break/>Acta Tropica, 2019</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><bold><italic toggle="yes">Clpc</italic></bold><break/>(Caseinolytic protease C)</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">For qPCR:<break/>POvaDif F, POvaDif R<break/>EvaGreen dye<break/>Optional nested snapback forward primer for additional qPCR<break/>(50 cycles)<break/>For High-Resolution Melting:<break/><italic toggle="yes">Pow</italic> Tm: 71.04&#x000b0;C<break/><italic toggle="yes">Poc</italic> Tm: 71.26&#x000b0;C</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Bangladesh and Ethiopia (n = 33)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">33</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">14</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">19</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">0</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><italic toggle="yes">P</italic>. ovale curtisi and P. ovale wallikeri able to be differentiated with a small &#x00394;Tm (0.2&#x000b0;C)<break/>88% specificity for <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> spp.</td></tr><tr><td align="center" colspan="9" rowspan="1">
<bold>Amplicon Deep Sequencing</bold>
</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><bold>Mitchell, et al.</bold> [<xref rid="pntd.0011274.ref026" ref-type="bibr">26</xref>]<break/>J Infect Dis, 2021</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>18S rRNA</bold>
</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Two round amplification; first using <italic toggle="yes">Plasmodium</italic> primers (20 cycles), then primers to ligate bar-coded Illumina adapters (40 cycles)<break/>SeekDeep (Version 3.0.1-dev) used to identify Po species based on sequence alignment</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Democratic Republic of Congo<break/>(n = 62)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">62</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">23</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">16</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">3</td><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">20 samples could not be speciated due to filtering cutoffs for quality assurance.<break/>Samples that were successfully sequenced were of higher parasitemia (median density 23 vs 9 parasites/uL, p = 0.007)</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec004"><title>Modifications to the nested PCR assay</title><p>The nPCR assay published by Calderaro, et al.[<xref rid="pntd.0011274.ref017" ref-type="bibr">17</xref>] was performed as described using HotStarTaq (Qiagen). First round amplification of <italic toggle="yes">Plasmodium ovale</italic> inclusive of <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> used rPLU1 (TCAAAGATTAAGCCATGCAAGTGA) and rPLU5 (CCTGTTGTTGCCTTAAACTTC), resulting in a ~800 bp PCR product. Second round amplification for <italic toggle="yes">Poc</italic> or <italic toggle="yes">Pow</italic> species-specific detection was performed using rOVA1 (ATTTTGAAGAATACACTAGG) and rOVA2 for <italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi</italic> (GGAAAAGGACACATTAATTGTATCCTAGTG), and rOVA1v (ATCTCTTTTGCTATTTTTTAGTATTGGAGA) and rOVA2v (GGAAAAGGACACTATAATGTATCCTAATA) for <italic toggle="yes">P</italic>. <italic toggle="yes">ovale wallikeri</italic>. This round resulted in a 787&#x02013;789 and 782 bp product for <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic>, respectively. A <italic toggle="yes">Plasmodium ovale curtisi</italic> 18S rRNA plasmid (MRA-180, BEI Resources) and genomic DNA from a sequence-confirmed <italic toggle="yes">Pow</italic> clinical sample from Tanzania were used as positive controls. When PCR products were not visualized on the 1% agarose gel using the standard conditions, the nPCR was repeated with adjustments made to cycle number, annealing temperatures, and input DNA volume to increase yield. The number of cycles was increased from 35 cycles in both rounds (70 total cycles) to as high as 40 cycles in round 1 and 45 cycles in round 2 (85 total cycles). Annealing temperatures were dropped in the second round species-specific PCR from 60&#x000b0;C and 58&#x000b0;C for <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic>, respectively, to as low as 58&#x000b0;C and 56&#x000b0;C, respectively. Finally, the input DNA volume was increased from 5 &#x003bc;L up to 10 &#x003bc;L for the round 1 PCR, but maintained at 5 &#x003bc;L for the round 2 PCR. A subset of nPCR products underwent Sanger sequencing for confirmation of species designations.</p></sec><sec id="sec005"><title>Modifications to real-time PCR assays</title><p>The sensitivity of the real-time PCR assays designed by Perandin, et. al [<xref rid="pntd.0011274.ref018" ref-type="bibr">18</xref>] and Calderaro, et. al [<xref rid="pntd.0011274.ref019" ref-type="bibr">19</xref>] to detect <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> was tested using dilutions of plasmids containing the small subunit ribosomal RNA gene (18S rRNA) specific to each species. The <italic toggle="yes">Poc</italic> 18S rRNA plasmid was obtained from BEI resources (MRA-180; GenBank: AF145337, 1,100 bp insert). The <italic toggle="yes">Pow</italic> plasmid control was created by cloning the first round nested PCR product of a Sanger-sequenced <italic toggle="yes">Pow</italic> clinical sample from Tanzania (MqTZ-0123) into a Topo 2.1kb vector using One Shot Top10 competent cells (Thermofisher Scientific). Real-time PCR was carried out using FastStart Universal Probe Master mix (ROX, Roche) and published primer and probe concentrations on a Bio-Rad CFX Connect Real-Time PCR Detection System.</p><p>To maximize detection sensitivity of both species, both assays were run in parallel to 50 cycles, instead of the originally published 45 and 55 cycles. For <italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi</italic> amplification, OVA-F (TTTTGAAGAATACATTAGGATACAATTAATG) and OVA-R (CATCGTTCCTCTAAGAAGCTTTACAAT) were used along with OVA (VIC) probe (CCTTTTCCCTATTCTACTTAATTCGCAATTCATG). For <italic toggle="yes">P</italic>. <italic toggle="yes">ovale wallikeri</italic> amplification, OVA-Fv (TTTTGAAGAATATATTAGGATACATTATAG) and OVA-R were used along with Ovav (FAM) probe (CCTTTTCCCTTTTCTACTTAATTCGCTATTATG). Product sizes for <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> were 127 and 130 bp, respectively. A common annealing temperature of 52.8&#x000b0;C was chosen for yielding similar Ct thresholds for detection of the same plasmid copy concentrations. At this lower annealing temperature, the assays could not be multiplexed into a duplex assay without detecting both species in each run regardless of the species-specific plasmid used, likely owing to the two real-time PCR assays having identical reverse primers and forward primers that differ by only two nucleotides, in addition to probes that also differ by only two nucleotides. Thus, species-specific assays were run side-by-side in separate reactions under the same conditions.</p></sec><sec id="sec006"><title>Real-time PCR of mono- and mixed species samples</title><p>The sensitivity of the modified qPCR assays for their respective 18S targets was tested for plasmid concentrations ranging from 10<sup>5</sup> down to 10<sup>&#x02212;1</sup> plasmid copies/<italic toggle="yes">&#x003bc;</italic>L. A limit of detection was calculated for each assay using a Probit analysis [<xref rid="pntd.0011274.ref027" ref-type="bibr">27</xref>]. To determine how the assays would perform for detecting samples with both species present, mock plasmid DNA control mixtures were created with <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> concentrations at a lower range (10<sup>2</sup> to 10<sup>&#x02212;1</sup> plasmid copies/<italic toggle="yes">&#x003bc;</italic>L) in ratios of 1:1, 1:2, 1:5, and 1:10 to simulate clinical samples. Each mixture was run 10 times using the qPCR assays, with the mean Ct value from the 10 runs reported. Based on these data, a classification scheme was developed for identifying mixed species infections (<italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic>).</p></sec><sec id="sec007"><title><italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> mixed species detection in clinical blood and mosquito samples</title><p>DNA extracted from blood samples from Cameroon (n = 16) and Tanzania (n = 22) previously identified as <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic>-positive based on an 18S qPCR that detects both <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species [<xref rid="pntd.0011274.ref026" ref-type="bibr">26</xref>] were used to compare the performance of the selected nPCR and modified qPCR assays. The Cameroon study was a prospective hospital based cross-sectional survey in the three main health facilities in the Dschang Health District in the West region of Cameroon that enrolled 431 patients between June-September 2020 that underwent screening for malaria per the attending physician [<xref rid="pntd.0011274.ref028" ref-type="bibr">28</xref>]. Tanzanian samples were drawn from symptomatic children screened for a malaria therapeutic efficacy study at Yombo Clinic in Bagamoyo in 2016&#x02013;2017 (YB- samples, [<xref rid="pntd.0011274.ref029" ref-type="bibr">29</xref>]) as well as asymptomatic children and adults undergoing screening for a malaria transmission study from 2018&#x02013;2019 [MqTZ- samples [<xref rid="pntd.0011274.ref008" ref-type="bibr">8</xref>,<xref rid="pntd.0011274.ref030" ref-type="bibr">30</xref>]]. Samples with lower Po 18S Ct values were deliberately chosen for study. The proportion of samples that amplified in each assay (nPCR and modified qPCR) and assay concordance for <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species identification were examined, including whether there was detection of mixed species infection.</p><p>Additionally, real-time PCR detection of <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species was performed on DNA extracted from 17 <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic>-positive mosquito midgut samples. These were obtained from mosquito feeding assays performed on <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic>-carriers in Tanzania using colony-reared <italic toggle="yes">Anopheles gambiae</italic> IFAKARA strain [<xref rid="pntd.0011274.ref008" ref-type="bibr">8</xref>], including both direct skin feeding and membrane feeding assays. Mosquito midguts that were dissected and oocyst-positive by microscopy at day 8 post-blood feeding were stored in either ethanol or DNA/RNA shield (Zymo Research) then subjected to DNAzol-based DNA extraction (Invitrogen). Extracted midgut DNA was amplified using <italic toggle="yes">Plasmodium</italic> genus-specific primers in a conventional PCR as a first round reaction [<xref rid="pntd.0011274.ref031" ref-type="bibr">31</xref>]. A second round <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> qPCR was performed on a 1:50 dilution of the first round product. Samples found to be positive were selected for further <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species identification. Dried blood spot or leukodepleted blood samples obtained at the time of mosquito feeding were also subjected to real-time PCR species detection to compare the presence and type of <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species detected in the blood vs. mosquito midgut samples.</p></sec></sec><sec sec-type="results" id="sec008"><title>Results</title><sec id="sec009"><title>Real-time PCR detection of <italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi</italic> and <italic toggle="yes">wallikeri</italic> in mono- and mixed infections</title><p>Run individually, both modified real-time PCR assays consistently detected down to 10<sup>0</sup> 18S plasmid copies/<italic toggle="yes">&#x003bc;</italic>L of their respective <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species, or the equivalent of roughly 0.2 parasites/<italic toggle="yes">&#x003bc;</italic>L assuming 6 copies of 18S rRNA per genome (<bold><xref rid="pntd.0011274.t002" ref-type="table">Table 2</xref></bold>). Since distilled water negative controls also sometimes demonstrated late cycle amplification for the <italic toggle="yes">Poc</italic> assay (mean Ct = 49.4, range 49.2&#x02013;49.9), Ct thresholds for positivity were set at Ct &#x0003c;49 for both species. Using these Ct thresholds, the limit of detection of the <italic toggle="yes">Poc</italic> assay based on Probit analysis was slightly lower than that of the <italic toggle="yes">Pow</italic> assay (0.6 plasmid copies/<italic toggle="yes">&#x003bc;</italic>L (95% CI 0.4&#x02013;1.6) vs. 4.5 plasmid copies/<italic toggle="yes">&#x003bc;</italic>L (95% CI 2.7&#x02013;17.7) for <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic>, respectively). At higher concentrations of <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> plasmids, on the order of 10<sup>3</sup> copies/<italic toggle="yes">&#x003bc;</italic>L, cross-reactivity between species was observed (<bold><xref rid="pntd.0011274.t002" ref-type="table">Table 2</xref></bold>).</p><table-wrap position="float" id="pntd.0011274.t002"><object-id pub-id-type="doi">10.1371/journal.pntd.0011274.t002</object-id><label>Table 2</label><caption><title>Limit of detection and cross-reactivity of real-time PCR assays targeting <italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi</italic> and <italic toggle="yes">wallikeri</italic>.</title><p>The mean Ct of the positive qPCR runs for each assay is shown for 18S plasmid concentrations ranging from 10<sup>5</sup> to 10<sup>&#x02212;1</sup> copies/<italic toggle="yes">&#x003bc;</italic>L.</p></caption><alternatives><graphic xlink:href="pntd.0011274.t002" id="pntd.0011274.t002g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" colspan="3" style="background-color:#F2F2F2" rowspan="1"><italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi</italic> assay</th><th align="center" colspan="3" style="background-color:#F2F2F2" rowspan="1"><italic toggle="yes">P</italic>. <italic toggle="yes">ovale wallikeri</italic> assay</th></tr><tr><th align="center" rowspan="2" colspan="1">18S plasmid copies/<italic toggle="yes">&#x003bc;</italic>L</th><th align="center" rowspan="1" colspan="1">Poc</th><th align="center" rowspan="1" colspan="1">Pow</th><th align="center" rowspan="2" colspan="1">18S plasmid copies/<italic toggle="yes">&#x003bc;</italic>L</th><th align="center" rowspan="1" colspan="1">Poc</th><th align="center" rowspan="1" colspan="1">Pow</th></tr><tr><th align="center" colspan="2" rowspan="1">No. positive qPCR runs (mean Ct)</th><th align="center" colspan="2" rowspan="1">No. positive qPCR runs (mean Ct)</th></tr></thead><tbody><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>5</bold>
</sup>
</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">5/5 (27.4)</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">2/5 (44.5)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>5</bold>
</sup>
</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">5/5 (48.0)</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">5/5 (26.9)</td></tr><tr><td align="center" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>4</bold>
</sup>
</td><td align="right" rowspan="1" colspan="1">5/5 (31.9)</td><td align="right" rowspan="1" colspan="1">2/5 (47.2)</td><td align="center" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>4</bold>
</sup>
</td><td align="right" rowspan="1" colspan="1">4/5 (48.9)</td><td align="right" rowspan="1" colspan="1">5/5 (30.8)</td></tr><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>3</bold>
</sup>
</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">5/5 (36.7)</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">2/5 (46.3)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>3</bold>
</sup>
</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">1/5 (47.2)</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">5/5 (35.1)</td></tr><tr><td align="center" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>2</bold>
</sup>
</td><td align="right" rowspan="1" colspan="1">10/10 (38.1)</td><td align="right" rowspan="1" colspan="1">0/10</td><td align="center" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>2</bold>
</sup>
</td><td align="right" rowspan="1" colspan="1">0/10</td><td align="right" rowspan="1" colspan="1">10/10 (39.4)</td></tr><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>1</bold>
</sup>
</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">10/10 (42.3)</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">0/10</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>1</bold>
</sup>
</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">1/10 (49.5)</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">10/10 (43.0)</td></tr><tr><td align="center" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>0</bold>
</sup>
</td><td align="right" rowspan="1" colspan="1">10/10 (46.6)</td><td align="right" rowspan="1" colspan="1">0/10</td><td align="center" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>0</bold>
</sup>
</td><td align="right" rowspan="1" colspan="1">1/10 (49.2)</td><td align="right" rowspan="1" colspan="1">10/10 (48.4)</td></tr><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>&#x02212;1</bold>
</sup>
</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">5/10 (47.9)</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">0/10</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">
<bold>10</bold>
<sup>
<bold>&#x02212;1</bold>
</sup>
</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">0/10</td><td align="right" style="background-color:#F2F2F2" rowspan="1" colspan="1">1/10 (49.2)</td></tr><tr><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">DI water</td><td align="center" colspan="2" style="background-color:#F2F2F2" rowspan="1">8/29 (49.4)</td><td align="center" colspan="3" style="background-color:#F2F2F2" rowspan="1">1/36 (48.9)</td></tr></tbody></table></alternatives></table-wrap><p>The cross-reactivity between assays at higher parasite densities (10<sup>3</sup> copies/<italic toggle="yes">&#x003bc;</italic>L or &#x0003e;100&#x02013;200 parasites/<italic toggle="yes">&#x003bc;</italic>L) could lead to misidentification of secondary species when none is present. The opposite may occur at lower parasite densities. To understand how the qPCR assays would perform for detecting mixed <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species infections at lower densities, mock plasmid mixtures were created to mimic different <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> ratios of species at different concentrations (<bold><xref rid="pntd.0011274.g001" ref-type="fig">Fig 1</xref></bold>). Both species remained detectable in the 1:1 mixtures down to their previous limits of detection. In fact, the sensitivity of the <italic toggle="yes">Pow</italic> assay appears &#x0201c;boosted&#x0201d; in the presence of <italic toggle="yes">Poc</italic> at the lowest concentration (10<sup>&#x02212;1</sup> copies/<italic toggle="yes">&#x003bc;</italic>L), likely due to low-level cross-species reactivity though none was observed at this level in the mono-species reactions. In the 1:2 and 1:5 mixtures, detection of the minor species was preserved when using a Ct threshold for positivity of &#x0003c;49. However, detection sensitivity of <italic toggle="yes">Pow</italic> as the minor species was compromised once the ratio reached 1:10.</p><fig position="float" id="pntd.0011274.g001"><object-id pub-id-type="doi">10.1371/journal.pntd.0011274.g001</object-id><label>Fig 1</label><caption><title>Performance of species-specific real-time PCR detection in mock mixtures of <italic toggle="yes">P</italic>. <italic toggle="yes">ovale curtisi</italic> and <italic toggle="yes">wallikeri</italic> 18S plasmid controls.</title><p>Mixtures were created either in equal proportions (A) or at ratios of 1:2, 1:5, and 1:10 (B). The number of positive runs and mean Ct of the positive qPCR runs for each species-specific assay is shown for 18S plasmid concentrations ranging from 10<sup>2</sup> to 10<sup>&#x02212;1</sup> copies/<italic toggle="yes">&#x003bc;</italic>L. A Ct value &#x0003c;49 was used to determine a positive run.</p></caption><graphic xlink:href="pntd.0011274.g001" position="float"/></fig><p>Based on the performance of the qPCR assays in mono- and mixed infections, an algorithm was developed to prevent false-positive detection of a secondary species within a mixed <italic toggle="yes">Poc/Pow</italic> infection. We found that this is more likely to happen if the majority species is abundant (Ct &#x0003c;39), leading to a cross-reactive false positive result for the other species that is indistinguishable from a small concentration of the minor species (Ct &#x0003e;44) (see data in <bold><xref rid="pntd.0011274.t002" ref-type="table">Table 2</xref></bold>). The resulting proposed classification system (<bold><xref rid="pntd.0011274.g002" ref-type="fig">Fig 2</xref></bold>) does not indicate the relative abundance of the two species, but simply whether both are present. This approach maintains 100% specificity for both species based on the simulated mono-infections in <xref rid="pntd.0011274.t002" ref-type="table">Table 2</xref> (0/55 and 0/45 false positives for <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic>, respectively, as we did not include the 10<sup>&#x02212;1</sup> plasmid copies/&#x003bc;L runs for <italic toggle="yes">Pow</italic> given the limit of detection of 4.5 plasmid copies/&#x003bc;L for the <italic toggle="yes">Pow</italic> assay). Based on the mock mixture data in <xref rid="pntd.0011274.g001" ref-type="fig">Fig 1</xref>, the modified qPCR assays paired with the proposed classification system achieve 84% sensitivity (280/335) for <italic toggle="yes">Poc</italic> (down to 10<sup>&#x02212;1</sup> plasmid copies/&#x003bc;L), and 94% sensitivity (239/255) for <italic toggle="yes">Pow</italic> (down to 10<sup>0</sup> plasmid copies/&#x003bc;L).</p><fig position="float" id="pntd.0011274.g002"><object-id pub-id-type="doi">10.1371/journal.pntd.0011274.g002</object-id><label>Fig 2</label><caption><title>Algorithm to determine the species of <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> malaria using 18S real-time PCR, whether as a single or mixed species infection.</title></caption><graphic xlink:href="pntd.0011274.g002" position="float"/></fig></sec><sec id="sec010"><title>Performance of real-time PCR in clinical samples</title><p>Thirty-seven clinical blood samples from Cameroon and Tanzania that previously tested positive for <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> using a pan-ovale species 18S rRNA real-time PCR [<xref rid="pntd.0011274.ref026" ref-type="bibr">26</xref>] were used to compare the performance of a published nested PCR [<xref rid="pntd.0011274.ref017" ref-type="bibr">17</xref>] and the adapted real-time PCR (qPCR) classification algorithm. Results were successfully obtained for 70% (26/37) of samples using qPCR versus 35% (13/37) of samples using published nested PCR conditions. When nested PCR was repeated with a greater number of cycles (up to 85 cycles across two rounds) and/or increased template DNA volume (up to 10 <italic toggle="yes">&#x003bc;</italic>L from 5 <italic toggle="yes">&#x003bc;</italic>L), 85% (23/27) could be successfully amplified (<bold><xref rid="pntd.0011274.g003" ref-type="fig">Fig 3</xref></bold> and <bold><xref rid="pntd.0011274.t003" ref-type="table">Table 3</xref></bold>). Identified species was confirmed by Sanger sequencing of nPCR products obtained from leukodepleted blood (LDB) samples.</p><fig position="float" id="pntd.0011274.g003"><object-id pub-id-type="doi">10.1371/journal.pntd.0011274.g003</object-id><label>Fig 3</label><caption><title>Gel electrophoresis showing nested PCR results for select samples from <xref rid="pntd.0011274.t003" ref-type="table">Table 3</xref>.</title><p>The second round products of the nested PCR assay were run on a 1% agarose gel for <italic toggle="yes">Poc</italic> (top) and <italic toggle="yes">Pow</italic> (bottom) detection. Fragment lengths of 787&#x02013;789 bp and 782 bp were expected for <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic>, respectively. The results of the nested PCR assay on these human clinical blood samples, determined by the presence of a band on the depicted gel, are displayed in <xref rid="pntd.0011274.t003" ref-type="table">Table 3</xref>.</p></caption><graphic xlink:href="pntd.0011274.g003" position="float"/></fig><table-wrap position="float" id="pntd.0011274.t003"><object-id pub-id-type="doi">10.1371/journal.pntd.0011274.t003</object-id><label>Table 3</label><caption><title>Comparison of <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species nested PCR and real-time PCR assays in field samples from Cameroon and Tanzania.</title><p><italic toggle="yes">Poc</italic> = <italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">curtisi; Pow</italic> = <italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">wallikeri</italic>. Samples not successfully amplified in species assays are indicated with &#x02013;.</p></caption><alternatives><graphic xlink:href="pntd.0011274.t003" id="pntd.0011274.t003g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="2" colspan="1"><italic toggle="yes">Po</italic> 18S (Ct value)</th><th align="center" rowspan="1" colspan="1">Nested PCR</th><th align="center" colspan="3" rowspan="1">Real-time PCR (Ct value)</th><th align="center" rowspan="2" colspan="1">Concordant</th><th align="center" rowspan="2" colspan="1">Discordant</th></tr><tr><th align="left" rowspan="1" colspan="1">Sample ID</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">Po</italic> species</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">curtisi</italic></th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">wallikeri</italic></th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">Po</italic> species</th></tr></thead><tbody><tr><td align="left" colspan="8" rowspan="1">
<bold>
<italic toggle="yes">Cameroon Samples (dried blood spots)</italic>
</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_151</td><td align="center" rowspan="1" colspan="1">27.1</td><td align="center" style="background-color:#6FA8DC" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">40.2</td><td align="center" rowspan="1" colspan="1">33.8</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1">
<italic toggle="yes">Pow + Poc</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_267</td><td align="center" rowspan="1" colspan="1">28.9</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">34.3</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_098</td><td align="center" rowspan="1" colspan="1">29.4</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">42.7</td><td align="center" rowspan="1" colspan="1">35.3</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1">
<italic toggle="yes">Pow + Poc</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">X</td></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_272</td><td align="center" rowspan="1" colspan="1">32.0</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">37.0</td><td align="center" rowspan="1" colspan="1">50.0</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_112</td><td align="center" rowspan="1" colspan="1">32.7</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">38.7</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_319</td><td align="center" rowspan="1" colspan="1">35.6</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">40.8</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_097</td><td align="center" rowspan="1" colspan="1">36.0</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">49.9</td><td align="center" rowspan="1" colspan="1">42.8</td><td align="center" style="background-color:#6FA8DC" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_255</td><td align="center" rowspan="1" colspan="1">36.9</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">43.1</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_125</td><td align="center" rowspan="1" colspan="1">36.9</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">47.5</td><td align="center" rowspan="1" colspan="1">45.6</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1">
<italic toggle="yes">Pow + Poc</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_138</td><td align="center" rowspan="1" colspan="1">40.0</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">47.0</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_100</td><td align="center" rowspan="1" colspan="1">40.1</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">49.2</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_101</td><td align="center" rowspan="1" colspan="1">40.3</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">47.1</td><td align="center" style="background-color:#6FA8DC" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_103</td><td align="center" rowspan="1" colspan="1">40.7</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DSG2020_096</td><td align="center" rowspan="1" colspan="1">41.7</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">49.8</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>
<italic toggle="yes">Tanzania Samples (dried blood spots)</italic>
</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">YB5006-MG<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">31.9</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">44.5</td><td align="center" rowspan="1" colspan="1">36.7</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-SN0423<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">32.7</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">44.9</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-SN0123<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">33.0</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">43.8</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">YB5042-MG<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">35.4</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">44.3</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-SN0386<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">35.9</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">48.5</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">YB5242-MG<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">37.2</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">45.1</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-SN0124<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">37.9</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">49.6</td><td align="center" rowspan="1" colspan="1">x</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">YB5070-MG<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">40.6</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">47.6</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">YB5198-MG<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">41.7</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-SN0411<xref rid="t003fn001" ref-type="table-fn"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">41.9</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="8" rowspan="1">
<bold>
<italic toggle="yes">Tanzania Samples (leukodepleted blood)</italic>
</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-0477<xref rid="t003fn002" ref-type="table-fn"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">33.7</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">38.7</td><td align="center" rowspan="1" colspan="1">46.4</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-0123<xref rid="t003fn002" ref-type="table-fn"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">33.8</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">43.8</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-0426<xref rid="t003fn002" ref-type="table-fn"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">34.0</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">40.0</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-0475<xref rid="t003fn002" ref-type="table-fn"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">35.6</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">41.1</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-0425<xref rid="t003fn002" ref-type="table-fn"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">40.1</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">47.3</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-0455<xref rid="t003fn002" ref-type="table-fn"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">42.1</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">48.5</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">X</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-2394</td><td align="center" rowspan="1" colspan="1">27.7</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">44.5</td><td align="center" rowspan="1" colspan="1">37.4</td><td align="center" style="background-color:#6D9EEB" rowspan="1" colspan="1">
<italic toggle="yes">Pow</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-2499 D14</td><td align="center" rowspan="1" colspan="1">29.8</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">37.3</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p><sup>a</sup>Nested PCR required increase in amplification cycles and/or increased volume of template DNA</p></fn><fn id="t003fn002"><p><sup>b</sup>Confirmed by Sanger sequencing of nPCR product</p></fn><fn id="t003fn003"><p>Note: Five samples did not amplify in either the nested PCR or real-time PCR assay.</p></fn></table-wrap-foot></table-wrap><p>Good concordance was observed among the 19 samples successfully amplified in both nested PCR and real-time PCR assays. There was 100% agreement with regard to identification of the major <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species present. However, real-time PCR additionally detected the presence of a second minor species in 2/19 samples that were not identified by nPCR (<bold><xref rid="pntd.0011274.t003" ref-type="table">Table 3</xref></bold>). Overall, among 28 unique <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic>-infected individuals with blood samples with species determined by real-time PCR or nested PCR listed in <xref rid="pntd.0011274.t003" ref-type="table">Table 3</xref>, 54% (15/28) were infected with <italic toggle="yes">Poc</italic>, 36% (10/28) were infected with <italic toggle="yes">Pow</italic>, and 11% (3/28) were identified as harboring mixed <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> species infections.</p><p>Mosquito-based xenodiagnosis revealed a much higher prevalence of mixed <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> infections than that identified from human clinical blood samples. Seventeen oocyst-positive mosquito midguts obtained from mosquito feeds performed on 9 <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> infected persons in Tanzania, that had previously tested qPCR-positive for <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic>, were available for species analysis. Fourteen of 17 (82%) midgut DNA samples successfully amplified in the <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species qPCR assays, of which 11/14 (79%) were positive for both <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> using the classification scheme outlined in <xref rid="pntd.0011274.g002" ref-type="fig">Fig 2</xref> (<bold><xref rid="pntd.0011274.t004" ref-type="table">Table 4</xref></bold>). Of 9 <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> carriers, only 2 had mixed <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> infections that could be detected in the blood at the time of mosquito feeding, but mosquito-based xenodiagnosis revealed that all but one (8/9) harbored both <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> and transmitted both species to mosquitoes. (<bold><xref rid="pntd.0011274.t004" ref-type="table">Table 4</xref></bold>).</p><table-wrap position="float" id="pntd.0011274.t004"><object-id pub-id-type="doi">10.1371/journal.pntd.0011274.t004</object-id><label>Table 4</label><caption><title>Real-time qPCR detection of <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic> species within <italic toggle="yes">P</italic>. <italic toggle="yes">ovale</italic>-infected mosquito midgut samples from Tanzania.</title><p><italic toggle="yes">Poc</italic> = <italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">curtisi; Pow</italic> = <italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">wallikeri</italic>.</p></caption><alternatives><graphic xlink:href="pntd.0011274.t004" id="pntd.0011274.t004g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="center" colspan="4" rowspan="1">Blood</th><th align="center" colspan="5" rowspan="1">Mosquito midgut</th></tr><tr><th align="center" rowspan="1" colspan="1">Sample ID</th><th align="center" rowspan="1" colspan="1">Po 18S Ct (blood)*</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">curtisi Ct</italic></th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">wallikeri Ct</italic></th><th align="center" rowspan="1" colspan="1">Po species identified</th><th align="center" rowspan="1" colspan="1">Midgut ID</th><th align="center" rowspan="1" colspan="1">Po 18S Ct (midgut)**</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">curtisi Ct</italic></th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic>.<italic toggle="yes">o</italic>. <italic toggle="yes">wallikeri Ct</italic></th><th align="center" rowspan="1" colspan="1">P.o. species identified</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">MqTZ-1610</td><td align="center" rowspan="4" colspan="1">32.2</td><td align="center" rowspan="4" colspan="1">34.8</td><td align="center" rowspan="4" colspan="1">N/A</td><td align="center" rowspan="4" style="background-color:#93C47D" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">L M2</td><td align="center" rowspan="1" colspan="1">13.6</td><td align="center" rowspan="1" colspan="1">39.3</td><td align="center" rowspan="1" colspan="1">43.3</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1">
<italic toggle="yes">Poc + Pow</italic>
</td></tr><tr><td align="center" rowspan="1" colspan="1">N2 M1</td><td align="center" rowspan="1" colspan="1">21.1</td><td align="center" rowspan="1" colspan="1">41.8</td><td align="center" rowspan="1" colspan="1">40.7</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1">
<italic toggle="yes">Pow + Poc</italic>
</td></tr><tr><td align="center" rowspan="1" colspan="1">R M5</td><td align="center" rowspan="1" colspan="1">21.9</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="center" rowspan="1" colspan="1">N1 M4</td><td align="center" rowspan="1" colspan="1">27.8</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="2" colspan="1">MqTZ-3863</td><td align="center" rowspan="2" colspan="1">32.3</td><td align="center" rowspan="2" colspan="1">41.7</td><td align="center" rowspan="2" colspan="1">38.2</td><td align="center" rowspan="2" style="background-color:#D0E0E3" colspan="1"><italic toggle="yes">Pow</italic> + <italic toggle="yes">Poc</italic></td><td align="center" rowspan="1" colspan="1">R M9</td><td align="center" rowspan="1" colspan="1">19.5</td><td align="center" rowspan="1" colspan="1">35.4</td><td align="center" rowspan="1" colspan="1">34.0</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1"><italic toggle="yes">Pow</italic> + <italic toggle="yes">Poc</italic></td></tr><tr><td align="center" rowspan="1" colspan="1">R M5</td><td align="center" rowspan="1" colspan="1">21.4</td><td align="center" rowspan="1" colspan="1">35.4</td><td align="center" rowspan="1" colspan="1">34.0</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1"><italic toggle="yes">Pow</italic> + <italic toggle="yes">Poc</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-3059</td><td align="center" rowspan="1" colspan="1">37.5</td><td align="center" rowspan="1" colspan="1">47.8</td><td align="center" rowspan="1" colspan="1">44.0</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1"><italic toggle="yes">Pow</italic> + <italic toggle="yes">Poc</italic></td><td align="center" rowspan="1" colspan="1">R M1</td><td align="center" rowspan="1" colspan="1">19.7</td><td align="center" rowspan="1" colspan="1">43.2</td><td align="center" rowspan="1" colspan="1">44.4</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1"><italic toggle="yes">Poc</italic> + <italic toggle="yes">Pow</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-191</td><td align="center" rowspan="1" colspan="1">39.9</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">A2 M17</td><td align="center" rowspan="1" colspan="1">19.1</td><td align="center" rowspan="1" colspan="1">40.5</td><td align="center" rowspan="1" colspan="1">35.1</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1"><italic toggle="yes">Pow</italic> + <italic toggle="yes">Poc</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-455</td><td align="center" rowspan="1" colspan="1">42.1</td><td align="center" rowspan="1" colspan="1">47.4</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">L M15</td><td align="center" rowspan="1" colspan="1">18.5</td><td align="center" rowspan="1" colspan="1">41.0</td><td align="center" rowspan="1" colspan="1">47.4</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1">
<italic toggle="yes">Poc + Pow</italic>
</td></tr><tr><td align="left" rowspan="2" colspan="1">MqTZ-167</td><td align="center" rowspan="2" colspan="1">42.8</td><td align="center" rowspan="2" colspan="1">&#x02013;</td><td align="center" rowspan="2" colspan="1">&#x02013;</td><td align="center" rowspan="2" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">L M1</td><td align="center" rowspan="1" colspan="1">16.0</td><td align="center" rowspan="1" colspan="1">31.1</td><td align="center" rowspan="1" colspan="1">30.6</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1">
<italic toggle="yes">Pow + Poc</italic>
</td></tr><tr><td align="center" rowspan="1" colspan="1">L M8</td><td align="center" rowspan="1" colspan="1">20.7</td><td align="center" rowspan="1" colspan="1">35.7</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">MqTZ-1077</td><td align="center" rowspan="1" colspan="1">44.3</td><td align="center" rowspan="1" colspan="1">49.5</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">L M1wk4</td><td align="center" rowspan="1" colspan="1">19.1</td><td align="center" rowspan="1" colspan="1">31.2</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td></tr><tr><td align="left" rowspan="2" colspan="1">MqTZ-1733</td><td align="center" rowspan="2" colspan="1">43.8</td><td align="center" rowspan="2" colspan="1">48.9</td><td align="center" rowspan="2" colspan="1">N/A</td><td align="center" rowspan="2" style="background-color:#93C47D" colspan="1">
<italic toggle="yes">Poc</italic>
</td><td align="center" rowspan="1" colspan="1">R M1</td><td align="center" rowspan="1" colspan="1">20.4</td><td align="center" rowspan="1" colspan="1">40.6</td><td align="center" rowspan="1" colspan="1">44.0</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1">
<italic toggle="yes">Poc + Pow</italic>
</td></tr><tr><td align="center" rowspan="1" colspan="1">L M1</td><td align="center" rowspan="1" colspan="1">28.1</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="3" colspan="1">MqTZ-799</td><td align="center" rowspan="3" colspan="1">44.7</td><td align="center" rowspan="3" colspan="1">&#x02013;</td><td align="center" rowspan="3" colspan="1">&#x02013;</td><td align="center" rowspan="3" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">R M1</td><td align="center" rowspan="1" colspan="1">23.2</td><td align="center" rowspan="1" colspan="1">46.7</td><td align="center" rowspan="1" colspan="1">45.5</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1"><italic toggle="yes">Pow</italic> + <italic toggle="yes">Poc</italic></td></tr><tr><td align="center" rowspan="1" colspan="1">L M1</td><td align="center" rowspan="1" colspan="1">24.2</td><td align="center" rowspan="1" colspan="1">46.5</td><td align="center" rowspan="1" colspan="1">N/A</td><td align="center" style="background-color:#93C47D" rowspan="1" colspan="1">
<italic toggle="yes">Poc</italic>
</td></tr><tr><td align="center" rowspan="1" colspan="1">L M2</td><td align="center" rowspan="1" colspan="1">28.7</td><td align="center" rowspan="1" colspan="1">45.7</td><td align="center" rowspan="1" colspan="1">48.1</td><td align="center" style="background-color:#D0E0E3" rowspan="1" colspan="1">
<italic toggle="yes">Poc + Pow</italic>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>*Cts reported are from leukodepleted blood samples collected at the time of mosquito feeding, except for MqTZ-191, in which DNA was extracted from a dried blood spot was used.</p></fn><fn id="t004fn002"><p>**Mosquito midgut qPCRs were performed on a 1:50 dilution of a conventional genus-level &#x0201c;round 1&#x0201d; PCR product, run out to 40 cycles</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec011"><title>Discussion</title><p>By modifying <italic toggle="yes">Poc</italic>- and <italic toggle="yes">Pow</italic>-specific 18S rRNA real-time PCR assays and developing a classification algorithm to detect mixed <italic toggle="yes">Poc/Pow</italic> infections that avoids false-positive detection due to cross-reactivity, we show that mixed <italic toggle="yes">Poc/Pow</italic> infections occur naturally (~11% in our initial blood survey) and may be much more common than anticipated (89% by mosquito-based xenodiagnosis in our small sample). Given their sympatric distribution, co-transmission of both <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> species within the same <italic toggle="yes">Anopheles</italic> mosquitoes is not unexpected. Frequent co-transmission means that the two species have ample opportunity to recombine within mosquitoes. Yet a species barrier appears to be firmly established, likely due to prior distinct evolutionary pathways before their present co-existence in human hosts [<xref rid="pntd.0011274.ref001" ref-type="bibr">1</xref>,<xref rid="pntd.0011274.ref002" ref-type="bibr">2</xref>,<xref rid="pntd.0011274.ref009" ref-type="bibr">9</xref>].</p><p>The higher frequency of <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> mixed infections we discovered among <italic toggle="yes">Po</italic>-infected mosquitoes compared to blood infection was a surprise. Xenodiagnosis has previously been suggested to be the most sensitive method for detecting human blood-stage infection, often detecting subpatent infections [<xref rid="pntd.0011274.ref032" ref-type="bibr">32</xref>&#x02013;<xref rid="pntd.0011274.ref034" ref-type="bibr">34</xref>] and, in our experience, sometimes detecting parasitemias circulating just below the limit of detection of PCR [<xref rid="pntd.0011274.ref035" ref-type="bibr">35</xref>]. Genetic diversity undetected by blood sampling can be revealed through mosquito sampling [<xref rid="pntd.0011274.ref036" ref-type="bibr">36</xref>&#x02013;<xref rid="pntd.0011274.ref039" ref-type="bibr">39</xref>] and attests to the sampling efficiency of mosquitoes and transmission efficiency of gametocytes. While our results could be explained by a simultaneous outbreak of both <italic toggle="yes">Po</italic> species, the mosquito feeding assays depicted in <xref rid="pntd.0011274.t004" ref-type="table">Table 4</xref> spanned two years of data collection. Rather, those exposed to one <italic toggle="yes">Po</italic> species may be more likely to also be exposed to the other <italic toggle="yes">Po</italic> species, with malaria exposure concentrated in a small proportion of the population who then serve as a reservoir [<xref rid="pntd.0011274.ref040" ref-type="bibr">40</xref>]. The role of relapse, in which persons once exposed remain latently infected in the liver, could also contribute to unexpected high rates of co-infection. <italic toggle="yes">Po</italic> species inoculated separately could relapse in unison when conditions are right. Larger molecular studies in other settings and including wild-caught mosquitoes are needed to verify our findings.</p><p>This work is not without limitations. First, our experiments to determine analytical sensitivity and develop a species classification scheme used plasmid controls, and we did not specifically test their robustness within blood or mosquito samples. Our finding that co-infection by both species was more common in mosquitoes than in human blood samples was surprising and needs to be validated with further studies. However, we expect lower assay sensitivity in mosquito samples due to low parasite burdens and to PCR inhibition rather than enhanced cross-reactivity or compromised diagnostic specificity. Second, our classification scheme is expected to underestimate mixed <italic toggle="yes">Poc/Pow</italic> infections when the majority species is at high density. Third, given the slightly greater sensitivity of the <italic toggle="yes">Poc</italic> real-time PCR assay over the <italic toggle="yes">Pow</italic> assay, we cannot draw firm conclusions about the relative prevalence of <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> in our surveys, aside from finding that both were represented in blood and mosquito samples. Fourth, though we showed excellent concordance of the real-time PCR assays with nested PCR and Sanger sequencing, we did not attempt to sequence our predominantly-mixed midgut samples to verify the presence of both species due to the paucity of DNA available and the bioinformatic challenge of detecting mixed <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> infections by targeted sequencing [<xref rid="pntd.0011274.ref036" ref-type="bibr">36</xref>&#x02013;<xref rid="pntd.0011274.ref026" ref-type="bibr">26</xref>]. Finally, some of our midgut PCR results involved high Ct values and might reflect contamination of samples, but the three-year time span of sample collection and the detection of <italic toggle="yes">Poc</italic> single species midguts (as well as midguts that did not amplify) make this less likely.</p><p>In conclusion, the real-time PCR approach described here represents an efficient method for detecting mixed <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> infections in both human clinical blood samples and mosquito midguts. Mixed <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> infections were commonly detected in mosquito midguts, and were also detected, albeit to a lesser degree, in both human dried blood spots and leukocyte-depleted blood samples. This suggests that the extent of mixed <italic toggle="yes">Poc</italic>/<italic toggle="yes">Pow</italic> infection may be greater than previously appreciated. Issues with cross-reactivity remain with the real-time PCR assays, which would best be resolved by using separate species-specific gene targets that would allow development of primer and probe sets with no potential for cross-reactivity [<xref rid="pntd.0011274.ref041" ref-type="bibr">41</xref>]. Much remains to be learned about <italic toggle="yes">Poc</italic> and <italic toggle="yes">Pow</italic> epidemiology in sub-Saharan Africa, including how they may be evolving in the face of malaria control efforts designed to target <italic toggle="yes">P</italic>. <italic toggle="yes">falciparum</italic>. Recognition of the limitation of current assays for detecting co-infection and continued development of better, more facile diagnostics will improve our ability to understand whether and how these two species potentially differ in their epidemiology, biology, and clinical manifestations. Our findings suggest that the degree to which these closely related but sympatric species co-circulate within their human and mosquito hosts may be underappreciated.</p></sec></body><back><ack><p>We thank the study participants, as well as community partners and research staff that carried out the field collections in Tanzania and Cameroon.</p></ack><ref-list><title>References</title><ref id="pntd.0011274.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Sutherland</surname><given-names>CJ</given-names></name>, <name><surname>Tanomsing</surname><given-names>N</given-names></name>, <name><surname>Nolder</surname><given-names>D</given-names></name>, <name><surname>Oguike</surname><given-names>M</given-names></name>, <name><surname>Jennison</surname><given-names>C</given-names></name>, <name><surname>Pukrittayakamee</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally</article-title>. <source>J Infect Dis</source>. <year>2010</year>;<volume>201</volume>: <fpage>1544</fpage>&#x02013;<lpage>1550</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1086/652240</pub-id>
<pub-id pub-id-type="pmid">20380562</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Rutledge</surname><given-names>GG</given-names></name>, <name><surname>B&#x000f6;hme</surname><given-names>U</given-names></name>, <name><surname>Sanders</surname><given-names>M</given-names></name>, <name><surname>Reid</surname><given-names>AJ</given-names></name>, <name><surname>Cotton</surname><given-names>JA</given-names></name>, <name><surname>Maiga-Ascofare</surname><given-names>O</given-names></name>, <etal>et al</etal>. <article-title>Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution</article-title>. <source>Nature</source>. <year>2017</year>;<volume>542</volume>: <fpage>101</fpage>&#x02013;<lpage>104</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature21038</pub-id>
<pub-id pub-id-type="pmid">28117441</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Mahittikorn</surname><given-names>A</given-names></name>, <name><surname>Masangkay</surname><given-names>FR</given-names></name>, <name><surname>Kotepui</surname><given-names>KU</given-names></name>, <name><surname>Milanez</surname><given-names>GDJ</given-names></name>, <name><surname>Kotepui</surname><given-names>M</given-names></name>. <article-title>Comparison of Plasmodium ovale curtisi and Plasmodium ovale wallikeri infections by a meta-analysis approach.</article-title>
<source>Sci Rep.</source>
<year>2021</year>;<volume>11</volume>: <fpage>6409</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-021-85398-w</pub-id>
<pub-id pub-id-type="pmid">33742015</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Yman</surname><given-names>V</given-names></name>, <name><surname>Wandell</surname><given-names>G</given-names></name>, <name><surname>Mutemi</surname><given-names>DD</given-names></name>, <name><surname>Miglar</surname><given-names>A</given-names></name>, <name><surname>Asghar</surname><given-names>M</given-names></name>, <name><surname>Hammar</surname><given-names>U</given-names></name>, <etal>et al</etal>. <article-title>Persistent transmission of Plasmodium malariae and Plasmodium ovale species in an area of declining Plasmodium falciparum transmission in eastern Tanzania.</article-title>
<source>PLoS Negl Trop Dis</source>. <year>2019</year>;<volume>13</volume>: <fpage>e0007414</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pntd.0007414</pub-id>
<pub-id pub-id-type="pmid">31136585</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Akala</surname><given-names>HM</given-names></name>, <name><surname>Watson</surname><given-names>OJ</given-names></name>, <name><surname>Mitei</surname><given-names>KK</given-names></name>, <name><surname>Juma</surname><given-names>DW</given-names></name>, <name><surname>Verity</surname><given-names>R</given-names></name>, <name><surname>Ingasia</surname><given-names>LA</given-names></name>, <etal>et al</etal>. <article-title>Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study</article-title>. <source>The Lancet Microbe</source>. <year>2021</year>;<volume>2</volume>: <fpage>e141</fpage>&#x02013;<lpage>e150</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S2666-5247(21)00009-4</pub-id>
<pub-id pub-id-type="pmid">35544189</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Sendor</surname><given-names>R</given-names></name>, <name><surname>Mitchell</surname><given-names>CL</given-names></name>, <name><surname>Chacky</surname><given-names>F</given-names></name>, <name><surname>Mohamed</surname><given-names>A</given-names></name>, <name><surname>Mhamilawa</surname><given-names>LE</given-names></name>, <name><surname>Molteni</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Non-falciparum malaria infections are as prevalent as P. falciparum among Tanzanian schoolchildren.</article-title>
<source>medRxiv.</source>
<year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/2022.06.07.22275625</pub-id></mixed-citation></ref><ref id="pntd.0011274.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Cook</surname><given-names>J</given-names></name>, <name><surname>Xu</surname><given-names>W</given-names></name>, <name><surname>Msellem</surname><given-names>M</given-names></name>, <name><surname>Vonk</surname><given-names>M</given-names></name>, <name><surname>Bergstr&#x000f6;m</surname><given-names>B</given-names></name>, <name><surname>Gosling</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar</article-title>. <source>J Infect Dis</source>. <year>2015</year>;<volume>211</volume>: <fpage>1476</fpage>&#x02013;<lpage>1483</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/infdis/jiu655</pub-id>
<pub-id pub-id-type="pmid">25429102</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Tarimo</surname><given-names>BB</given-names></name>, <name><surname>Nyasembe</surname><given-names>VO</given-names></name>, <name><surname>Ngasala</surname><given-names>B</given-names></name>, <name><surname>Basham</surname><given-names>C</given-names></name>, <name><surname>Rutagi</surname><given-names>IJ</given-names></name>, <name><surname>Muller</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Seasonality and transmissibility of Plasmodium ovale in Bagamoyo District, Tanzania.</article-title>
<source>Parasit Vectors</source>. <year>2022</year>;<volume>15</volume>: <fpage>56</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13071-022-05181-2</pub-id>
<pub-id pub-id-type="pmid">35164867</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Sutherland</surname><given-names>CJ</given-names></name>. <article-title>Persistent Parasitism: The Adaptive Biology of Malariae and Ovale Malaria</article-title>. <source>Trends Parasitol</source>. <year>2016</year>;<volume>32</volume>: <fpage>808</fpage>&#x02013;<lpage>819</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.pt.2016.07.001</pub-id>
<pub-id pub-id-type="pmid">27480365</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Nolder</surname><given-names>D</given-names></name>, <name><surname>Oguike</surname><given-names>MC</given-names></name>, <name><surname>Maxwell-Scott</surname><given-names>H</given-names></name>, <name><surname>Niyazi</surname><given-names>HA</given-names></name>, <name><surname>Smith</surname><given-names>V</given-names></name>, <name><surname>Chiodini</surname><given-names>PL</given-names></name>, <etal>et al</etal>. <article-title>An observational study of malaria in British travellers: Plasmodium ovale wallikeri and Plasmodium ovale curtisi differ significantly in the duration of latency</article-title>. <source>BMJ Open</source>. <year>2013</year>;<fpage>3</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2013-002711</pub-id>
<pub-id pub-id-type="pmid">23793668</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Rojo-Marcos</surname><given-names>G</given-names></name>, <name><surname>Rubio-Mu&#x000f1;oz</surname><given-names>JM</given-names></name>, <name><surname>Ram&#x000ed;rez-Olivencia</surname><given-names>G</given-names></name>, <name><surname>Garc&#x000ed;a-Bujalance</surname><given-names>S</given-names></name>, <name><surname>Elcuaz-Romano</surname><given-names>R</given-names></name>, <name><surname>D&#x000ed;az-Men&#x000e9;ndez</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Comparison of imported Plasmodium ovale curtisi and P. ovale wallikeri infections among patients in Spain, 2005&#x02013;2011</article-title>. <source>Emerg Infect Dis</source>. <year>2014</year>;<volume>20</volume>: <fpage>409</fpage>&#x02013;<lpage>416</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3201/eid2003.130745</pub-id>
<pub-id pub-id-type="pmid">24572501</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>R</given-names></name>, <name><surname>Li</surname><given-names>S</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Yang</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Qian</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Characterization of Plasmodium ovale spp. imported from Africa to Henan Province, China.</article-title>
<source>Sci Rep.</source>
<year>2019</year>;<volume>9</volume>: <fpage>2191</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-019-38629-0</pub-id>
<pub-id pub-id-type="pmid">30778106</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Groger</surname><given-names>M</given-names></name>, <name><surname>Veletzky</surname><given-names>L</given-names></name>, <name><surname>Lalremruata</surname><given-names>A</given-names></name>, <name><surname>Cattaneo</surname><given-names>C</given-names></name>, <name><surname>Mischlinger</surname><given-names>J</given-names></name>, <name><surname>Manego Zoleko</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting</article-title>. <source>Clin Infect Dis</source>. <year>2019</year>;<volume>69</volume>: <fpage>2119</fpage>&#x02013;<lpage>2126</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cid/ciz131</pub-id>
<pub-id pub-id-type="pmid">31066448</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Fuehrer</surname><given-names>H-P</given-names></name>, <name><surname>Campino</surname><given-names>S</given-names></name>, <name><surname>Sutherland</surname><given-names>CJ</given-names></name>. <article-title>The primate malaria parasites Plasmodium malariae, Plasmodium brasilianum and Plasmodium ovale spp.: genomic insights into distribution, dispersal and host transitions.</article-title>
<source>Malar J</source>. <year>2022</year>;<volume>21</volume>: <fpage>138</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12936-022-04151-4</pub-id>
<pub-id pub-id-type="pmid">35505317</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Woldearegai</surname><given-names>TG</given-names></name>, <name><surname>Lalremruata</surname><given-names>A</given-names></name>, <name><surname>Nguyen</surname><given-names>TT</given-names></name>, <name><surname>Gmeiner</surname><given-names>M</given-names></name>, <name><surname>Veletzky</surname><given-names>L</given-names></name>, <name><surname>Tazemda-Kuitsouc</surname><given-names>GB</given-names></name>, <etal>et al</etal>. <article-title>Characterization of Plasmodium infections among inhabitants of rural areas in Gabon.</article-title>
<source>Sci Rep.</source>
<year>2019</year>;<volume>9</volume>: <fpage>9784</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-019-46194-9</pub-id>
<pub-id pub-id-type="pmid">31278305</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Fuehrer</surname><given-names>H-P</given-names></name>, <name><surname>Habler</surname><given-names>VE</given-names></name>, <name><surname>Fally</surname><given-names>MA</given-names></name>, <name><surname>Harl</surname><given-names>J</given-names></name>, <name><surname>Starzengruber</surname><given-names>P</given-names></name>, <name><surname>Swoboda</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Plasmodium ovale in Bangladesh: genetic diversity and the first known evidence of the sympatric distribution of Plasmodium ovale curtisi and Plasmodium ovale wallikeri in southern Asia</article-title>. <source>Int J Parasitol</source>. <year>2012</year>;<volume>42</volume>: <fpage>693</fpage>&#x02013;<lpage>699</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijpara.2012.04.015</pub-id>
<pub-id pub-id-type="pmid">22633951</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Calderaro</surname><given-names>A</given-names></name>, <name><surname>Piccolo</surname><given-names>G</given-names></name>, <name><surname>Perandin</surname><given-names>F</given-names></name>, <name><surname>Gorrini</surname><given-names>C</given-names></name>, <name><surname>Peruzzi</surname><given-names>S</given-names></name>, <name><surname>Zuelli</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Genetic polymorphisms influence Plasmodium ovale PCR detection accuracy</article-title>. <source>J Clin Microbiol</source>. <year>2007</year>;<volume>45</volume>: <fpage>1624</fpage>&#x02013;<lpage>1627</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.02316-06</pub-id>
<pub-id pub-id-type="pmid">17360843</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Fuehrer</surname><given-names>H-P</given-names></name>, <name><surname>Stadler</surname><given-names>M-T</given-names></name>, <name><surname>Buczolich</surname><given-names>K</given-names></name>, <name><surname>Bloeschl</surname><given-names>I</given-names></name>, <name><surname>Noedl</surname><given-names>H</given-names></name>. <article-title>Two techniques for simultaneous identification of Plasmodium ovale curtisi and Plasmodium ovale wallikeri by use of the small-subunit rRNA gene</article-title>. <source>J Clin Microbiol</source>. <year>2012</year>;<volume>50</volume>: <fpage>4100</fpage>&#x02013;<lpage>4102</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.02180-12</pub-id>
<pub-id pub-id-type="pmid">23015675</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Perandin</surname><given-names>F</given-names></name>, <name><surname>Manca</surname><given-names>N</given-names></name>, <name><surname>Calderaro</surname><given-names>A</given-names></name>, <name><surname>Piccolo</surname><given-names>G</given-names></name>, <name><surname>Galati</surname><given-names>L</given-names></name>, <name><surname>Ricci</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis</article-title>. <source>J Clin Microbiol</source>. <year>2004</year>;<volume>42</volume>: <fpage>1214</fpage>&#x02013;<lpage>1219</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.42.3.1214-1219.2004</pub-id>
<pub-id pub-id-type="pmid">15004078</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Calderaro</surname><given-names>A</given-names></name>, <name><surname>Piccolo</surname><given-names>G</given-names></name>, <name><surname>Gorrini</surname><given-names>C</given-names></name>, <name><surname>Montecchini</surname><given-names>S</given-names></name>, <name><surname>Rossi</surname><given-names>S</given-names></name>, <name><surname>Medici</surname><given-names>MC</given-names></name>, <etal>et al</etal>. <article-title>A new real-time PCR for the detection of Plasmodium ovale wallikeri.</article-title>
<source>PLoS One.</source>
<year>2012</year>;<volume>7</volume>: <fpage>e48033</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0048033</pub-id>
<pub-id pub-id-type="pmid">23110165</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Fuehrer</surname><given-names>H-P</given-names></name>, <name><surname>Noedl</surname><given-names>H</given-names></name>. <article-title>Recent advances in detection of Plasmodium ovale: implications of separation into the two species Plasmodium ovale wallikeri and Plasmodium ovale curtisi</article-title>. <source>J Clin Microbiol</source>. <year>2014</year>;<volume>52</volume>: <fpage>387</fpage>&#x02013;<lpage>391</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.02760-13</pub-id>
<pub-id pub-id-type="pmid">24478466</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Oguike</surname><given-names>MC</given-names></name>, <name><surname>Betson</surname><given-names>M</given-names></name>, <name><surname>Burke</surname><given-names>M</given-names></name>, <name><surname>Nolder</surname><given-names>D</given-names></name>, <name><surname>Stothard</surname><given-names>JR</given-names></name>, <name><surname>Kleinschmidt</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities</article-title>. <source>Int J Parasitol</source>. <year>2011</year>;<volume>41</volume>: <fpage>677</fpage>&#x02013;<lpage>683</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijpara.2011.01.004</pub-id>
<pub-id pub-id-type="pmid">21315074</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Tanomsing</surname><given-names>N</given-names></name>, <name><surname>Imwong</surname><given-names>M</given-names></name>, <name><surname>Sutherland</surname><given-names>CJ</given-names></name>, <name><surname>Dolecek</surname><given-names>C</given-names></name>, <name><surname>Hien</surname><given-names>TT</given-names></name>, <name><surname>Nosten</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Genetic marker suitable for identification and genotyping of Plasmodium ovale curtisi and Plasmodium ovale wallikeri</article-title>. <source>J Clin Microbiol</source>. <year>2013</year>;<volume>51</volume>: <fpage>4213</fpage>&#x02013;<lpage>4216</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.01527-13</pub-id>
<pub-id pub-id-type="pmid">24068009</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Nijhuis</surname><given-names>RHT</given-names></name>, <name><surname>van Lieshout</surname><given-names>L</given-names></name>, <name><surname>Verweij</surname><given-names>JJ</given-names></name>, <name><surname>Claas</surname><given-names>ECJ</given-names></name>, <name><surname>Wessels</surname><given-names>E</given-names></name>. <article-title>Multiplex real-time PCR for diagnosing malaria in a non-endemic setting: a prospective comparison to conventional methods</article-title>. <source>Eur J Clin Microbiol Infect Dis</source>. <year>2018</year>;<volume>37</volume>: <fpage>2323</fpage>&#x02013;<lpage>2329</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10096-018-3378-4</pub-id>
<pub-id pub-id-type="pmid">30259214</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Lamien-Meda</surname><given-names>A</given-names></name>, <name><surname>Fuehrer</surname><given-names>H-P</given-names></name>, <name><surname>Noedl</surname><given-names>H</given-names></name>. <article-title>Novel high resolution melting (HRM) and snapback assays for simultaneous detection and differentiation of Plasmodium ovale spp.</article-title>
<source>Acta Trop</source>. <year>2019</year>;<volume>192</volume>: <fpage>75</fpage>&#x02013;<lpage>81</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.actatropica.2019.01.018</pub-id>
<pub-id pub-id-type="pmid">30711423</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Mitchell</surname><given-names>CL</given-names></name>, <name><surname>Brazeau</surname><given-names>NF</given-names></name>, <name><surname>Keeler</surname><given-names>C</given-names></name>, <name><surname>Mwandagalirwa</surname><given-names>MK</given-names></name>, <name><surname>Tshefu</surname><given-names>AK</given-names></name>, <name><surname>Juliano</surname><given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>Under the Radar: Epidemiology of Plasmodium ovale in the Democratic Republic of the Congo</article-title>. <source>J Infect Dis</source>. <year>2021</year>;<volume>223</volume>: <fpage>1005</fpage>&#x02013;<lpage>1014</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/infdis/jiaa478</pub-id>
<pub-id pub-id-type="pmid">32766832</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Canchola</surname><given-names>JA</given-names></name>. <source>Limit of detection (LoD) estimation using parametric curve fitting to (hit) rate data: The LoD_est SAS macro</source>. [cited 3 Jan 2023]. Available: <ext-link xlink:href="https://support.sas.com/resources/papers/proceedings16/1720-" ext-link-type="uri">https://support.sas.com/resources/papers/proceedings16/1720-</ext-link><year>2016</year>.pdf</mixed-citation></ref><ref id="pntd.0011274.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Ali</surname><given-names>IM</given-names></name>, <name><surname>Tchuenkam</surname><given-names>VPK</given-names></name>, <name><surname>Colton</surname><given-names>M</given-names></name>, <name><surname>Stittleburg</surname><given-names>V</given-names></name>, <name><surname>Mitchell</surname><given-names>C</given-names></name>, <name><surname>Gaither</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Arboviruses as an unappreciated cause of non-malarial acute febrile illness in the Dschang Health District of western Cameroon.</article-title>
<source>PLoS Negl Trop Dis</source>. <year>2022</year>;<volume>16</volume>: <fpage>e0010790</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pntd.0010790</pub-id>
<pub-id pub-id-type="pmid">36223421</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Topazian</surname><given-names>HM</given-names></name>, <name><surname>Moser</surname><given-names>KA</given-names></name>, <name><surname>Ngasala</surname><given-names>B</given-names></name>, <name><surname>Oluoch</surname><given-names>PO</given-names></name>, <name><surname>Forconi</surname><given-names>CS</given-names></name>, <name><surname>Mhamilawa</surname><given-names>LE</given-names></name>, <etal>et al</etal>. <article-title>Low Complexity of Infection Is Associated With Molecular Persistence of Plasmodium falciparum in Kenya and Tanzania.</article-title>
<source>Frontiers in Epidemiology.</source>
<year>2022</year>;<fpage>2</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fepid.2022.852237</pub-id></mixed-citation></ref><ref id="pntd.0011274.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Markwalter</surname><given-names>CF</given-names></name>, <name><surname>Ngasala</surname><given-names>B</given-names></name>, <name><surname>Mowatt</surname><given-names>T</given-names></name>, <name><surname>Basham</surname><given-names>C</given-names></name>, <name><surname>Park</surname><given-names>Z</given-names></name>, <name><surname>Loya</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Direct Comparison of Standard and Ultrasensitive PCR for the Detection of Plasmodium falciparum from Dried Blood Spots in Bagamoyo, Tanzania</article-title>. <source>Am J Trop Med Hyg</source>. <year>2021</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4269/ajtmh.20-1233</pub-id>
<pub-id pub-id-type="pmid">33556035</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Miguel-Oteo</surname><given-names>M</given-names></name>, <name><surname>Jiram</surname><given-names>AI</given-names></name>, <name><surname>Ta-Tang</surname><given-names>TH</given-names></name>, <name><surname>Lanza</surname><given-names>M</given-names></name>, <name><surname>Hisam</surname><given-names>S</given-names></name>, <name><surname>Rubio</surname><given-names>JM</given-names></name>. <article-title>Nested multiplex PCR for identification and detection of human Plasmodium species including Plasmodium knowlesi</article-title>. <source>Asian Pac J Trop Med</source>. <year>2017</year>;<volume>10</volume>: <fpage>299</fpage>&#x02013;<lpage>304</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.apjtm.2017.03.014</pub-id>
<pub-id pub-id-type="pmid">28442114</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Gouagna</surname><given-names>LC</given-names></name>, <name><surname>Yao</surname><given-names>F</given-names></name>, <name><surname>Yameogo</surname><given-names>B</given-names></name>, <name><surname>Dabir&#x000e9;</surname><given-names>RK</given-names></name>, <name><surname>Ou&#x000e9;draogo</surname><given-names>J-B</given-names></name>. <article-title>Comparison of field-based xenodiagnosis and direct membrane feeding assays for evaluating host infectiousness to malaria vector Anopheles gambiae</article-title>. <source>Acta Trop</source>. <year>2014</year>;<volume>130</volume>: <fpage>131</fpage>&#x02013;<lpage>139</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.actatropica.2013.10.022</pub-id>
<pub-id pub-id-type="pmid">24262642</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Muirhead-Thomson</surname><given-names>RC</given-names></name>. <article-title>The malarial infectivity of an African village population to mosquitoes (Anopheles gambiae); a random xenodiagnostic survey.</article-title>
<source>Am J Trop Med Hyg</source>. <year>1957</year>;<volume>6</volume>: <fpage>971</fpage>&#x02013;<lpage>979</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4269/ajtmh.1957.6.971</pub-id>
<pub-id pub-id-type="pmid">13487967</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Almeida</surname><given-names>GG</given-names></name>, <name><surname>Costa</surname><given-names>PAC</given-names></name>, <name><surname>Araujo M da</surname><given-names>S</given-names></name>, <name><surname>Gomes</surname><given-names>GR</given-names></name>, <name><surname>Carvalho</surname><given-names>AF</given-names></name>, <name><surname>Figueiredo</surname><given-names>MM</given-names></name>, <etal>et al</etal>. <article-title>Asymptomatic Plasmodium vivax malaria in the Brazilian Amazon: Submicroscopic parasitemic blood infects Nyssorhynchus darlingi</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2021</year>;<volume>15</volume>: <fpage>e0009077</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pntd.0009077</pub-id>
<pub-id pub-id-type="pmid">34714821</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>JT</given-names></name>, <name><surname>Parr</surname><given-names>JB</given-names></name>, <name><surname>Ngasala</surname><given-names>B</given-names></name>. <article-title>Non-falciparum malaria in Africa and learning from P. vivax in Asia</article-title>. <source>Clin Infect Dis</source>. <year>2019</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cid/ciz780</pub-id>
<pub-id pub-id-type="pmid">31408098</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Grignard</surname><given-names>L</given-names></name>, <name><surname>Gon&#x000e7;alves</surname><given-names>BP</given-names></name>, <name><surname>Early</surname><given-names>AM</given-names></name>, <name><surname>Daniels</surname><given-names>RF</given-names></name>, <name><surname>Tiono</surname><given-names>AB</given-names></name>, <name><surname>Guelb&#x000e9;ogo</surname><given-names>WM</given-names></name>, <etal>et al</etal>. <article-title>Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feeding</article-title>. <source>Int J Parasitol</source>. <year>2018</year>;<volume>48</volume>: <fpage>671</fpage>&#x02013;<lpage>677</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijpara.2018.02.005</pub-id>
<pub-id pub-id-type="pmid">29738740</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Nwakanma</surname><given-names>D</given-names></name>, <name><surname>Kheir</surname><given-names>A</given-names></name>, <name><surname>Sowa</surname><given-names>M</given-names></name>, <name><surname>Dunyo</surname><given-names>S</given-names></name>, <name><surname>Jawara</surname><given-names>M</given-names></name>, <name><surname>Pinder</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>High gametocyte complexity and mosquito infectivity of Plasmodium falciparum in the Gambia</article-title>. <source>Int J Parasitol</source>. <year>2008</year>;<volume>38</volume>: <fpage>219</fpage>&#x02013;<lpage>227</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ijpara.2007.07.003</pub-id>
<pub-id pub-id-type="pmid">17709108</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Morlais</surname><given-names>I</given-names></name>, <name><surname>Nsango</surname><given-names>SE</given-names></name>, <name><surname>Toussile</surname><given-names>W</given-names></name>, <name><surname>Abate</surname><given-names>L</given-names></name>, <name><surname>Annan</surname><given-names>Z</given-names></name>, <name><surname>Tchioffo</surname><given-names>MT</given-names></name>, <etal>et al</etal>. <article-title>Plasmodium falciparum mating patterns and mosquito infectivity of natural isolates of gametocytes.</article-title>
<source>PLoS One</source>. <year>2015</year>;<volume>10</volume>: <fpage>e0123777</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0123777</pub-id>
<pub-id pub-id-type="pmid">25875840</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Balasubramanian</surname><given-names>S</given-names></name>, <name><surname>Rahman</surname><given-names>RS</given-names></name>, <name><surname>Lon</surname><given-names>C</given-names></name>, <name><surname>Parobek</surname><given-names>C</given-names></name>, <name><surname>Ubalee</surname><given-names>R</given-names></name>, <name><surname>Hathaway</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Efficient Transmission of Mixed Plasmodium falciparum/vivax Infections From Humans to Mosquitoes</article-title>. <source>J Infect Dis</source>. <year>2020</year>;<volume>221</volume>: <fpage>428</fpage>&#x02013;<lpage>437</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/infdis/jiz388</pub-id>
<pub-id pub-id-type="pmid">31549156</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Corder</surname><given-names>RM</given-names></name>, <name><surname>Arez</surname><given-names>AP</given-names></name>, <name><surname>Ferreira</surname><given-names>MU</given-names></name>. <article-title>Individual variation in Plasmodium vivax malaria risk: Are repeatedly infected people just unlucky?</article-title>
<source>PLoS Negl Trop Dis</source>. <year>2023</year>;<volume>17</volume>: <fpage>e0011020</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pntd.0011020</pub-id>
<pub-id pub-id-type="pmid">36634044</pub-id>
</mixed-citation></ref><ref id="pntd.0011274.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>He</surname><given-names>W</given-names></name>, <name><surname>Sendor</surname><given-names>R</given-names></name>, <name><surname>Potlapalli</surname><given-names>VR</given-names></name>, <name><surname>Kashamuka</surname><given-names>MM</given-names></name>, <name><surname>Tshefu</surname><given-names>AK</given-names></name>, <name><surname>Phanzu</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>A novel duplex qualitative real-time PCR assay for the detection and differentiation of Plasmodium ovale curtisi and Plasmodium ovale wallikeri malaria</article-title>. <source>medRxiv</source>. <year>2023</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1101/2023.10.31.23297819</pub-id>
<pub-id pub-id-type="pmid">37961397</pub-id>
</mixed-citation></ref></ref-list></back><sub-article article-type="aggregated-review-documents" id="pntd.0011274.r001" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pntd.0011274.r001</article-id><title-group><article-title>Decision Letter 0</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jaffe</surname><given-names>Charles L.</given-names></name><role>Section Editor</role></contrib><contrib contrib-type="author"><name><surname>Mireji</surname><given-names>Paul O.</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2023 Jaffe, Mireji</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Jaffe, Mireji</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pntd.0011274" id="rel-obj001" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">3 Jul 2023</named-content>
</p><p>Dear Dr. Lin,</p><p>Thank you very much for submitting your manuscript "Real-time PCR detection of mixed&#x000a0;Plasmodium ovale curtisi&#x000a0;and&#x000a0;wallikeri species&#x000a0;infections in human and mosquito hosts" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments. </p><p>We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.</p><p>When you are ready to resubmit, please upload the following:</p><p>[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.&#x000a0;Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p><p>[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). </p><p>Important additional instructions are given below your reviewer comments.</p><p>Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.</p><p>Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p><p>Sincerely,</p><p>Paul O. Mireji, PhD</p><p>Academic Editor</p><p>PLOS Neglected Tropical Diseases</p><p>Charles Jaffe</p><p>Section Editor</p><p>PLOS Neglected Tropical Diseases</p><p>***********************</p><p>Reviewer's Responses to Questions</p><p>
<bold>Key Review Criteria Required for Acceptance?</bold>
</p><p>As you describe the new analyses required for acceptance, please consider the following:</p><p>
<bold>Methods</bold>
</p><p>-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?</p><p>-Is the study design appropriate to address the stated objectives?</p><p>-Is the population clearly described and appropriate for the hypothesis being tested?</p><p>-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?</p><p>-Were correct statistical analysis used to support conclusions?</p><p>-Are there concerns about ethical or regulatory requirements being met?</p><p>Reviewer #1: see below</p><p>Reviewer #2: The authors have introduced an optimized protocol that effectively discriminates between Plasmodium ovale curtisi (Poc) and Plasmodium ovale wallikeri (Pow) in mixed P. ovale species infections. However, there are certain aspects regarding the description of the population (sampling) used for protocol optimization that require clarification. Notably, the qualitative and quantitative details of the study population are not explicitly provided. For instance, in the discussion of the modified PCR on lines 114 and 119, the sample size remains unclear. In order to enhance the methodology section, it is imperative to present a more coherent and sequential flow of the protocol, rather than a fragmented description of the modifications, accompanied by appropriate statistical treatment. Addressing these concerns will greatly enhance the transparency and reproducibility of the study.</p><p>Reviewer #3: The methods should give more details on equipment. What real-time PCR machine was used?</p><p>--------------------</p><p>
<bold>Results</bold>
</p><p>-Does the analysis presented match the analysis plan?</p><p>-Are the results clearly and completely presented?</p><p>-Are the figures (Tables, Images) of sufficient quality for clarity?</p><p>Reviewer #1: see below</p><p>Reviewer #2: The methodology for determining the sensitivity and specificity values presented in lines 183-184 requires further clarification. It is not apparent how these values were derived, and a detailed explanation of true and false positives would enhance the transparency of the data provided. Additionally, it would be beneficial to describe the criteria used for establishing the Ct value threshold. Elaborating on these aspects will provide a clearer understanding of the methodology employed and strengthen the interpretation of the results.</p><p>Reviewer #3: Regarding &#x0201c;&#x02026;detected down to 100 18S plasmid copies/&#x003bc;L of their respective P. ovale species, or the equivalent of 1-2 parasites/&#x003bc;L assuming 5-8 copies of 18S rRNA per genome&#x0201d;: Why not just say &#x02018;one&#x02019;? (100 = 1) So this is saying that 1 plasmid copy is equivalent to 1-2 parasites assuming 5-8 copies per genome. It does not quite make sense. Unless it was supposed to be 101.</p><p>Ct &#x0003c; 49 is still a pretty high threshold for positivity. Melting or dissociation curve analysis would have helped to confirm that amplicons are of target sequences.</p><p>Though I understand the algorithm conceptually, it seems to be based on somewhat arbitrary thresholds. Further I fear that it is based on the cross-activity first observed at 103 (or 1000) copies. As the next previous dilution tested where no cross-activity was observed was at 102 (100) copies, the threshold of cross-reactivity is not clear. It could be 200 copies&#x02026; The observed mixed infection in this study, especially of the surprising mosquito experiment results, should be confirmed with amplicon sequencing.</p><p>--------------------</p><p>
<bold>Conclusions</bold>
</p><p>-Are the conclusions supported by the data presented?</p><p>-Are the limitations of analysis clearly described?</p><p>-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?</p><p>-Is public health relevance addressed?</p><p>Reviewer #1: see below</p><p>Reviewer #2: (No Response)</p><p>Reviewer #3: (No Response)</p><p>--------------------</p><p>
<bold>Editorial and Data Presentation Modifications?</bold>
</p><p>Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend &#x0201c;Minor Revision&#x0201d; or &#x0201c;Accept&#x0201d;. </p><p>Reviewer #1: (No Response)</p><p>Reviewer #2: (No Response)</p><p>Reviewer #3: The last two sentences of the introduction are results and discussion and should not be part of the introduction. The introduction should simply give background and rationale for the study and state the objectives.</p><p>The beginning of the discussion should be part of the introduction.</p><p>If at the beginning of a sentence, genus names should not be abbreviated, even if previously defined.</p><p>I don&#x02019;t think that Tables should be formatted like Table 1 with all these paragraphs within cells. And the entire methods section should not be in landscape.</p><p>--------------------</p><p>
<bold>Summary and General Comments</bold>
</p><p>Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.</p><p>Reviewer #1: The authors describe the detection of Plasmodium ovale wallikeri and P. o. curtisi in humans and mosquitoes using a real-time PCR. The assay is of high interest and might allow specification at low parasitemia/DNA amounts. The quality of the manuscript is very good. </p><p>Some modifications are recommended:</p><p>Title &#x02013; species can be deleted; it is recommended to change to &#x02026; Plasmodium ovale curtisi and P. ovale wallikeri infections&#x02026;</p><p>Line 21 &#x02013; malaria species is not correct. Malaria is a disease; pathogen/parasite/Plasmodium species cause diseases/infections</p><p>Methods &#x02013; Please provide primer names and sequences (and bp sizes of PCR products)</p><p>Methods/Discussion &#x02013; Table 1 - There are several other protocols to discriminate PoC/PoW (e.g. Fuehrer et al. JCM; Lamien-Meda et al. Acta Tropica). Please check literature.</p><p>Reviewer #2: (No Response)</p><p>Reviewer #3: Though I can see considerable work gone into this study, I must recommend a major revision to clarify the significance of the study and to validate some of the confusing findings.</p><p>It would be helpful if the paper would early on and in the abstract/summary say why it is important to identify mixed Po infections. It is not clear to me. The introduction should have more background on why it is important to identify mixed Poc and Pow infections. Is there a reason that this could contribute to disease or understanding of epidemiology somehow?</p><p>--------------------</p><p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosntds/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p><p>If you choose &#x0201c;no&#x0201d;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p><p>Reviewer #1: Yes: Hans-Peter Fuehrer</p><p>Reviewer #2: No</p><p>Reviewer #3: No</p><p>Figure Files:</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com.&#x000a0;PACE" ext-link-type="uri">https://pacev2.apexcovantage.com.&#x000a0;PACE</ext-link> helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>.</p><p>Data Requirements:</p><p>Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: <ext-link xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5" ext-link-type="uri">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>.</p><p>Reproducibility:</p><p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols</ext-link></p><supplementary-material id="pntd.0011274.s001" position="float" content-type="local-data"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">PNTD-D-23-00401.pdf</named-content></p></caption><media xlink:href="pntd.0011274.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></body></sub-article><sub-article article-type="author-comment" id="pntd.0011274.r002"><front-stub><article-id pub-id-type="doi">10.1371/journal.pntd.0011274.r002</article-id><title-group><article-title>Author response to Decision Letter 0</article-title></title-group><related-article ext-link-type="doi" xlink:href="10.1371/journal.pntd.0011274" id="rel-obj002" related-article-type="editor-report"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">13 Sep 2023</named-content>
</p><supplementary-material id="pntd.0011274.s002" position="float" content-type="local-data"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers Letter.docx</named-content></p></caption><media xlink:href="pntd.0011274.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></body></sub-article><sub-article article-type="aggregated-review-documents" id="pntd.0011274.r003" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pntd.0011274.r003</article-id><title-group><article-title>Decision Letter 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jaffe</surname><given-names>Charles L.</given-names></name><role>Section Editor</role></contrib><contrib contrib-type="author"><name><surname>Mireji</surname><given-names>Paul O.</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2023 Jaffe, Mireji</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Jaffe, Mireji</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pntd.0011274" id="rel-obj003" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">17 Oct 2023</named-content>
</p><p>Dear Dr. Lin,</p><p>Thank you very much for submitting your manuscript "Real-time PCR detection of mixed Plasmodium ovale curtisi and wallikeri infections in human and mosquito hosts" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. </p><p>From our editorial perspective, we think the manuscript will be if the following aspects are addressed </p><p>1) At the end of the introduction, the authors discusses results that have not yet been presented and conclusions appears to be "prematurely" drawn.</p><p>"Our optimized protocol for running parallel Poc and Pow species-specific qPCRs detected mixed Po species infection in a smaller proportion of blood samples from Tanzania and Cameroon. However, this percentage was much higher in Po-positive mosquito midgut samples derived from mosquito feeding studies in Tanzania, raising the possibility that mixed Poc/Pow infections may be more common than currently appreciated."</p><p>2)I|n the discussion section, the information at the beginning fits better ( strengthen the introduction) than with the discussion. Can the authors consider this suggestion? </p><p>"Improved detection and rising prevalence of non-falciparum malaria species in sub-Saharan Africa [4&#x02013;6,8] has spurred interest in better defining their epidemiology and biology [3,9,32,33]. Now recognized as two separate species, Plasmodium ovale curtisi (Poc) and Plasmodium ovale wallikeri (Pow) appear to circulate sympatrically, yet it appears &#x0003c;20 cases of Poc/Pow co-infection have been reported across &#x0003e;35 studies encompassing 1,515 P. ovale cases in the literature [3,13,15,16,22,26]."</p><p>Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. </p><p>When you are ready to resubmit, please upload the following:</p><p>[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. </p><p>Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out</p><p>[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).</p><p>Important additional instructions are given below your reviewer comments. </p><p>Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p><p>Sincerely,</p><p>Paul O. Mireji, PhD</p><p>Academic Editor</p><p>PLOS Neglected Tropical Diseases</p><p>Charles Jaffe</p><p>Section Editor</p><p>PLOS Neglected Tropical Diseases</p><p>***********************</p><p>From our editorial perspective, we think the manuscript will be if the following aspects are addressed </p><p>1) At the end of the introduction, the authors discusses results that have not yet been presented and conclusions appears to be "prematurely" drawn.</p><p>"Our optimized protocol for running parallel Poc and Pow species-specific qPCRs detected mixed Po species infection in a smaller proportion of blood samples from Tanzania and Cameroon. However, this percentage was much higher in Po-positive mosquito midgut samples derived from mosquito feeding studies in Tanzania, raising the possibility that mixed Poc/Pow infections may be more common than currently appreciated."</p><p>2)I|n the discussion section, the information at the beginning fits better ( strengthen the introduction) than with the discussion. Can the authors consider this suggestion? </p><p>"Improved detection and rising prevalence of non-falciparum malaria species in sub-Saharan Africa [4&#x02013;6,8] has spurred interest in better defining their epidemiology and biology [3,9,32,33]. Now recognized as two separate species, Plasmodium ovale curtisi (Poc) and Plasmodium ovale wallikeri (Pow) appear to circulate sympatrically, yet it appears &#x0003c;20 cases of Poc/Pow co-infection have been reported across &#x0003e;35 studies encompassing 1,515 P. ovale cases in the literature [3,13,15,16,22,26]."</p><p>Reviewer's Responses to Questions</p><p>
<bold>Key Review Criteria Required for Acceptance?</bold>
</p><p>As you describe the new analyses required for acceptance, please consider the following:</p><p>
<bold>Methods</bold>
</p><p>-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?</p><p>-Is the study design appropriate to address the stated objectives?</p><p>-Is the population clearly described and appropriate for the hypothesis being tested?</p><p>-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?</p><p>-Were correct statistical analysis used to support conclusions?</p><p>-Are there concerns about ethical or regulatory requirements being met?</p><p>Reviewer #2: (No Response)</p><p>Reviewer #3: (No Response)</p><p>--------------------</p><p>
<bold>Results</bold>
</p><p>-Does the analysis presented match the analysis plan?</p><p>-Are the results clearly and completely presented?</p><p>-Are the figures (Tables, Images) of sufficient quality for clarity?</p><p>Reviewer #2: (No Response)</p><p>Reviewer #3: (No Response)</p><p>--------------------</p><p>
<bold>Conclusions</bold>
</p><p>-Are the conclusions supported by the data presented?</p><p>-Are the limitations of analysis clearly described?</p><p>-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?</p><p>-Is public health relevance addressed?</p><p>Reviewer #2: (No Response)</p><p>Reviewer #3: (No Response)</p><p>--------------------</p><p>
<bold>Editorial and Data Presentation Modifications?</bold>
</p><p>Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend &#x0201c;Minor Revision&#x0201d; or &#x0201c;Accept&#x0201d;. </p><p>Reviewer #2: (No Response)</p><p>Reviewer #3: (No Response)</p><p>--------------------</p><p>
<bold>Summary and General Comments</bold>
</p><p>Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.</p><p>Reviewer #2: This is a much improved version of the MS. The concerns have been sufficiently addressed.</p><p>Reviewer #3: (No Response)</p><p>--------------------</p><p>PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosntds/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p><p>If you choose &#x0201c;no&#x0201d;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link>.</p><p>Reviewer #2: No</p><p>Reviewer #3: No</p><p>Figure Files:</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link xlink:href="https://pacev2.apexcovantage.com" ext-link-type="uri">https://pacev2.apexcovantage.com</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <email>figures@plos.org</email>.</p><p>Data Requirements:</p><p>Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: <ext-link xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5" ext-link-type="uri">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>.</p><p>Reproducibility:</p><p>To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols</ext-link></p><p>References</p><p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.</p></body></sub-article><sub-article article-type="author-comment" id="pntd.0011274.r004"><front-stub><article-id pub-id-type="doi">10.1371/journal.pntd.0011274.r004</article-id><title-group><article-title>Author response to Decision Letter 1</article-title></title-group><related-article ext-link-type="doi" xlink:href="10.1371/journal.pntd.0011274" id="rel-obj004" related-article-type="editor-report"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>2</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">14 Nov 2023</named-content>
</p><supplementary-material id="pntd.0011274.s003" position="float" content-type="local-data"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers Letter.docx</named-content></p></caption><media xlink:href="pntd.0011274.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></body></sub-article><sub-article article-type="editor-report" id="pntd.0011274.r005" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pntd.0011274.r005</article-id><title-group><article-title>Decision Letter 2</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jaffe</surname><given-names>Charles L.</given-names></name><role>Section Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2023 Charles L. Jaffe</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Charles L. Jaffe</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pntd.0011274" id="rel-obj005" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>2</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">21 Nov 2023</named-content>
</p><p>Dear Dr. Lin,</p><p>We are pleased to inform you that your manuscript 'Real-time PCR detection of mixed Plasmodium ovale curtisi and wallikeri infections in human and mosquito hosts' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.</p><p>Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.</p><p>Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.</p><p>IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.</p><p>Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.</p><p>Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.</p><p>Best regards,</p><p>Charles L. Jaffe, Ph.D.</p><p>Section Editor</p><p>PLOS Neglected Tropical Diseases</p><p>Charles Jaffe</p><p>Section Editor</p><p>PLOS Neglected Tropical Diseases</p><p>***********************************************************</p></body></sub-article><sub-article article-type="editor-report" id="pntd.0011274.r006" specific-use="acceptance-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pntd.0011274.r006</article-id><title-group><article-title>Acceptance letter</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jaffe</surname><given-names>Charles L.</given-names></name><role>Section Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2023 Charles L. Jaffe</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Charles L. Jaffe</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pntd.0011274" id="rel-obj006" related-article-type="reviewed-article"/></front-stub><body><p>
<named-content content-type="letter-date">30 Nov 2023</named-content>
</p><p>Dear Dr. Lin,</p><p>We are delighted to inform you that your manuscript, "Real-time PCR detection of mixed <italic toggle="yes">Plasmodium ovale curtisi</italic> and <italic toggle="yes">wallikeri</italic> infections in human and mosquito hosts," has been formally accepted for publication in PLOS Neglected Tropical Diseases.</p><p>We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.</p><p>The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.</p><p>Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p><p>Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. </p><p>Best regards,</p><p>Shaden Kamhawi</p><p>co-Editor-in-Chief</p><p>PLOS Neglected Tropical Diseases</p><p>Paul Brindley</p><p>co-Editor-in-Chief</p><p>PLOS Neglected Tropical Diseases</p></body></sub-article></article>
